{
  "meta": {
    "id": "test7",
    "title": "Nephrology",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A patient presents with the following laboratory values: Which of the following best describes the patient\u2019s acid\u2013base status?",
      "options": [
        {
          "label": "A",
          "text": "Anion gap metabolic acidosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anion gap metabolic acidosis plus metabolic alkalosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anion gap metabolic acidosis plus normal anion gap metabolic acidosis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Normal anion gap metabolic acidosis",
          "correct": false
        }
      ],
      "correct_answer": "C. Anion gap metabolic acidosis plus normal anion gap metabolic acidosis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20130956.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Anion gap metabolic acidosis plus normal anion gap metabolic acidosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Anion gap metabolic acidosis: Does not account for the extra bicarbonate drop.</li><li>\u2022 Option A. Anion gap metabolic acidosis:</li><li>\u2022 Option B. Anion gap metabolic acidosis plus metabolic alkalosis: Would typically yield a higher bicarbonate, often with \u0394\u2013\u0394 > 2.</li><li>\u2022 Option B. Anion gap metabolic acidosis plus metabolic alkalosis:</li><li>\u2022 Option D. Normal anion gap metabolic acidosis: The elevated AG of 18 rules out a pure normal AG acidosis.</li><li>\u2022 Option D. Normal anion gap metabolic acidosis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When you see a low bicarbonate and an elevated anion gap, use the Delta\u2013Delta Ratio. A ratio <1 suggests coexisting anion gap and normal anion gap metabolic acidosis. Top of Form</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "881bbe68",
      "audio": ""
    },
    {
      "text": "A patient has the following laboratory findings: Which of the following is the most likely acid\u2013base status",
      "options": [
        {
          "label": "A",
          "text": "Acute respiratory acidosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute respiratory alkalosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chronic respiratory acidosis with metabolic compensation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metabolic alkalosis with respiratory compensation",
          "correct": true
        }
      ],
      "correct_answer": "D. Metabolic alkalosis with respiratory compensation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131016.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Metabolic alkalosis with respiratory compensation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Acute respiratory acidosis would present with a low pH (acidemia) and high PCO\u2082, not alkalemia.</li><li>\u2022 Option A. Acute respiratory acidosis</li><li>\u2022 Option B. Acute respiratory alkalosis would show a high pH but a low PCO\u2082.</li><li>\u2022 Option B. Acute respiratory alkalosis</li><li>\u2022 Option C. Chronic respiratory acidosis with metabolic compensation typically results in a less elevated pH; 7.55 is too alkalotic for that scenario.</li><li>\u2022 Option C. Chronic respiratory acidosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A high bicarbonate and alkalemic pH accompanied by an elevated, appropriately compensated PCO\u2082 is characteristic of metabolic alkalosis with respiratory compensation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d6f7bf9f",
      "audio": ""
    },
    {
      "text": "A 68-year-old man with chronic liver disease is admitted for worsening abdominal distension. His laboratory findings are as follows: Sodium (Na\u207a): 140 mEq/L Chloride (Cl\u207b): 115 mEq/L Bicarbonate (HCO\u2083\u207b): 26 mEq/L Albumin: 1.2 g/dL Which of the following best explains the anion gap?",
      "options": [
        {
          "label": "A",
          "text": "Laboratory error in chloride measurement",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypoalbuminemia leading to a reduction in the anion gap",
          "correct": true
        },
        {
          "label": "C",
          "text": "Unmeasured cation excess due to multiple myeloma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metabolic alkalosis",
          "correct": false
        }
      ],
      "correct_answer": "B. Hypoalbuminemia leading to a reduction in the anion gap",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Hypoalbuminemia leading to a reduction in the anion gap</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Laboratory error in chloride measurement is unlikely because the sodium, chloride, and bicarbonate levels are consistent with normal measurement trends.</li><li>\u2022 Option A. Laboratory error in chloride measurement</li><li>\u2022 Option C. Unmeasured cation excess due to multiple myeloma can reduce the anion gap through excess cationic monoclonal proteins, but this patient has no evidence of multiple myeloma, and hypoalbuminemia is a more likely explanation.</li><li>\u2022 Option C. Unmeasured cation excess due to multiple myeloma</li><li>\u2022 Option D. Metabolic alkalosis does not typically result in a low anion gap. It may raise bicarbonate, but that does not account for the reduction in the anion gap observed here.</li><li>\u2022 Option D. Metabolic alkalosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The anion gap is significantly influenced by albumin levels. Hypoalbuminemia decreases the anion gap by reducing unmeasured anions. In this case, the corrected anion gap appropriately accounts for the low albumin, ruling out other causes.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6179e7e8",
      "audio": ""
    },
    {
      "text": "A 60-year-old diabetic patient presents with fever and altered mental status. On examination, his blood pressure is 70/40 mm Hg and his pulse rate is 134/min. He has crackles over the left infrascapular region. Lab results are as follows: Na\u207a: 138 mEq/L, Cl\u207b: 98 mEq/L, HCO\u2083\u207b: 10 mEq/L, BUN: 58 mg/dL, Creatinine: 3.0 mg/dL, Blood glucose: 180 mg/dL. Which of the following best explains the anion gap?",
      "options": [
        {
          "label": "A",
          "text": "Excessive administration of normal saline",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ketone body production",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hyperchloremia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Accumulation of lactate",
          "correct": true
        }
      ],
      "correct_answer": "D. Accumulation of lactate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Accumulation of lactate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Excessive administration of normal saline: Causes a normal anion gap (hyperchloremic) acidosis, not an elevated one.</li><li>\u2022 Option A. Excessive administration of normal saline:</li><li>\u2022 Option B. Ketone body production: Are less likely because the glucose of 180 mg/dL is not highly suggestive of diabetic ketoacidosis, and the clinical picture points more toward sepsis.</li><li>\u2022 Option B. Ketone body production:</li><li>\u2022 Option C. Hyperchloremia: Results in Normal Anion Gap Metabolic Acidosis</li><li>\u2022 Option C. Hyperchloremia:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In a hypotensive, septic patient, a high anion gap metabolic acidosis most often indicates lactic acidosis secondary to poor tissue perfusion.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8f211819",
      "audio": ""
    },
    {
      "text": "A 50-year-old man with hypokalemia and recurrent kidney stones presents with normal anion gap metabolic acidosis. His urinary anion gap is measured and found to be positive. Which of the following best explains this finding?",
      "options": [
        {
          "label": "A",
          "text": "Excess NH\u2084\u207a excretion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Low NH\u2084\u207a excretion",
          "correct": true
        },
        {
          "label": "C",
          "text": "High Urinary Chloride",
          "correct": false
        },
        {
          "label": "D",
          "text": "Excessive urinary acidification",
          "correct": false
        }
      ],
      "correct_answer": "B. Low NH\u2084\u207a excretion",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Low NH\u2084\u207a excretion</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Excess NH\u2084\u207a excretion : Would cause a negative urinary anion gap, more typical of GI bicarbonate loss rather than a renal defect.</li><li>\u2022 Option A. Excess NH\u2084\u207a excretion</li><li>\u2022 negative</li><li>\u2022 Option C. High urinary chloride: Alone does not necessarily produce a positive urinary anion gap; in fact, increased urinary chloride often makes the gap more negative or closer to zero.</li><li>\u2022 Option C. High urinary chloride:</li><li>\u2022 positive</li><li>\u2022 Option D. Excessive urinary acidification : Is not consistent with a positive urinary anion gap; with adequate NH\u2084\u207a excretion and acidification, the gap would be negative.</li><li>\u2022 Option D. Excessive urinary acidification</li><li>\u2022 positive</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A positive urinary anion gap in a patient with normal anion gap metabolic acidosis typically indicates low NH\u2084\u207a excretion and points to a renal rather than GI cause of the acidosis (e.g., distal RTA).</li><li>\u27a4 positive</li><li>\u27a4 low NH\u2084\u207a excretion</li><li>\u27a4 renal</li><li>\u27a4 GI</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f3ac9ec7",
      "audio": ""
    },
    {
      "text": "A patient has the following laboratory findings: Which of the following is the most likely acid-base status?",
      "options": [
        {
          "label": "A",
          "text": "Acute metabolic acidosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute respiratory acidosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acute respiratory acidosis plus acute metabolic acidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chronic respiratory acidosis",
          "correct": true
        }
      ],
      "correct_answer": "D. Chronic respiratory acidosis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131110.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Chronic respiratory acidosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Acute metabolic acidosis : Incorrect because metabolic acidosis would present with a low bicarbonate and compensatory low PCO\u2082, not elevated PCO\u2082.</li><li>\u2022 Option A. Acute metabolic acidosis</li><li>\u2022 Option B. Acute respiratory acidosis : Incorrect because bicarbonate is elevated, indicating renal compensation, which occurs only in chronic conditions.</li><li>\u2022 Option B. Acute respiratory acidosis</li><li>\u2022 Option C. Acute respiratory acidosis plus acute metabolic acidosis : Incorrect because the elevated bicarbonate rules out a primary metabolic acidosis.</li><li>\u2022 Option C. Acute respiratory acidosis plus acute metabolic acidosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Chronic respiratory acidosis occurs with prolonged CO\u2082 retention, leading to renal compensation by increasing bicarbonate. Differentiating acute from chronic respiratory acidosis requires assessing bicarbonate levels, which increase significantly only in chronic conditions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "769cdd58",
      "audio": ""
    },
    {
      "text": "A patient has the following laboratory findings: Which of the following is the most likely acid-base status?",
      "options": [
        {
          "label": "A",
          "text": "Anion gap metabolic acidosis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Anion gap metabolic acidosis plus metabolic alkalosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anion gap metabolic acidosis plus normal anion gap metabolic acidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Normal anion gap metabolic acidosis",
          "correct": false
        }
      ],
      "correct_answer": "A. Anion gap metabolic acidosis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131127.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Anion gap metabolic acidosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option B. Anion gap metabolic acidosis : Plus metabolic alkalosis is incorrect because there is no elevated bicarbonate or evidence of alkalosis.</li><li>\u2022 Option B. Anion gap metabolic acidosis</li><li>\u2022 Option C. Anion gap metabolic acidosis plus normal anion gap metabolic acidosis: Is incorrect as there is no hyperchloremia to suggest an additional non-anion gap acidosis.</li><li>\u2022 Option C. Anion gap metabolic acidosis plus normal anion gap metabolic acidosis:</li><li>\u2022 Option D. Normal anion gap metabolic acidosis : Is incorrect as the elevated anion gap clearly indicates an anion gap metabolic acidosis.</li><li>\u2022 Option D. Normal anion gap metabolic acidosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Delta-delta ratio analysis helps differentiate pure anion gap metabolic acidosis from mixed acid-base disorders. A ratio within the normal range (1\u20132) confirms a single anion gap metabolic acidosis without additional acid-base disturbances.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "769cdd58",
      "audio": ""
    },
    {
      "text": "A patient has the following laboratory findings: Which of the following is the most likely acid-base status?",
      "options": [
        {
          "label": "A",
          "text": "Acute respiratory acidosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic respiratory acidosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Metabolic acidosis plus primary respiratory alkalosis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Metabolic acidosis with appropriate respiratory compensation",
          "correct": false
        }
      ],
      "correct_answer": "C. Metabolic acidosis plus primary respiratory alkalosis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131148.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Metabolic acidosis plus primary respiratory alkalosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Acute respiratory acidosis : Is incorrect because the PCO\u2082 is low, not elevated, ruling out respiratory acidosis.</li><li>\u2022 Option A. Acute respiratory acidosis</li><li>\u2022 Option B. Chronic respiratory acidosis : Is incorrect because the bicarbonate would be elevated due to renal compensation, not reduced.</li><li>\u2022 Option B. Chronic respiratory acidosis</li><li>\u2022 Option D. Metabolic acidosis with appropriate respiratory compensation : Is incorrect because the PCO\u2082 is lower than the expected range, indicating an additional primary respiratory alkalosis.</li><li>\u2022 Option D. Metabolic acidosis with appropriate respiratory compensation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The delta ratio and Winter\u2019s formula are essential tools for evaluating mixed acid-base disorders. A PCO\u2082 lower than expected in metabolic acidosis suggests an additional respiratory alkalosis. This highlights the importance of calculating expected compensation to detect hidden mixed disorders.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "769cdd58",
      "audio": ""
    },
    {
      "text": "A patient has the following laboratory findings: Which of the following is the most likely acid-base status?",
      "options": [
        {
          "label": "A",
          "text": "Acute metabolic acidosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute respiratory acidosis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Acute respiratory acidosis plus acute metabolic acidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chronic metabolic acidosis with respiratory compensation",
          "correct": false
        }
      ],
      "correct_answer": "B. Acute respiratory acidosis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131209.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Acute respiratory acidosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Acute metabolic acidosis : Incorrect because metabolic acidosis would present with low bicarbonate and compensatory low PCO\u2082, which are not observed here.</li><li>\u2022 Option A. Acute metabolic acidosis</li><li>\u2022 Option C. Acute respiratory acidosis plus acute metabolic acidosis : Incorrect because the bicarbonate is normal, ruling out metabolic acidosis.</li><li>\u2022 Option C. Acute respiratory acidosis plus acute metabolic acidosis</li><li>\u2022 Option D. Chronic metabolic acidosis with respiratory compensation : Incorrect because chronic metabolic acidosis would present with low bicarbonate and low PCO\u2082 as compensation.</li><li>\u2022 Option D. Chronic metabolic acidosis with respiratory compensation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Acute respiratory acidosis is characterized by an acidemic pH, elevated PCO\u2082, and normal bicarbonate (before compensation occurs). Compensation for respiratory acidosis takes days, so normal bicarbonate suggests an acute process.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "769cdd58",
      "audio": ""
    },
    {
      "text": "A patient has the following laboratory findings: Which of the following is the most likely acid-base status?",
      "options": [
        {
          "label": "A",
          "text": "Acute metabolic acidosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute respiratory alkalosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acute respiratory alkalosis plus acute metabolic alkalosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chronic respiratory alkalosis with metabolic compensation",
          "correct": true
        }
      ],
      "correct_answer": "D. Chronic respiratory alkalosis with metabolic compensation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131229.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Chronic respiratory alkalosis with metabolic compensation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Acute metabolic acidosis : Incorrect, as acidosis would result in a low pH, not the alkalotic pH seen here.</li><li>\u2022 Option A. Acute metabolic acidosis</li><li>\u2022 Option B. Acute respiratory alkalosis : Incorrect because bicarbonate levels are reduced, indicating renal compensation, which occurs only in chronic conditions.</li><li>\u2022 Option B. Acute respiratory alkalosis</li><li>\u2022 Option C. Acute respiratory alkalosis plus acute metabolic alkalosis : Incorrect because the bicarbonate is low, ruling out metabolic alkalosis.</li><li>\u2022 Option C. Acute respiratory alkalosis plus acute metabolic alkalosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Chronic respiratory alkalosis occurs with prolonged hyperventilation, leading to renal compensation by reducing bicarbonate levels. The distinction between acute and chronic respiratory alkalosis is based on bicarbonate levels, which decrease significantly only in chronic conditions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "769cdd58",
      "audio": ""
    },
    {
      "text": "A patient has the following laboratory findings: Which of the following is the most likely acid-base status?",
      "options": [
        {
          "label": "A",
          "text": "Anion gap metabolic acidosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anion gap metabolic acidosis plus metabolic alkalosis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Anion gap metabolic acidosis plus normal anion gap metabolic acidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Normal anion gap metabolic acidosis",
          "correct": false
        }
      ],
      "correct_answer": "B. Anion gap metabolic acidosis plus metabolic alkalosis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131245.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Anion gap metabolic acidosis plus metabolic alkalosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A . Anion gap metabolic acidosis: This is partially correct but incomplete as it doesn't account for the mixed disorder indicated by the delta ratio > 2.</li><li>\u2022 Option A</li><li>\u2022 Option C . Anion gap metabolic acidosis plus normal anion gap metabolic acidosis: Incorrect because the delta ratio > 2 indicates alkalosis, not a second acidosis. In mixed normal gap and high gap acidosis, the delta ratio would be < 1.</li><li>\u2022 Option C</li><li>\u2022 Option D . Normal anion gap metabolic acidosis: Clearly incorrect as the AG is significantly elevated at 40.</li><li>\u2022 Option D</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Use the delta ratio to identify mixed acid-base disorders. A delta ratio > 2 suggests concurrent metabolic alkalosis along with anion gap metabolic acidosis, which can occur in conditions like diabetic ketoacidosis with vomiting or lactic acidosis with diuretic use.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "769cdd58",
      "audio": ""
    },
    {
      "text": "A patient has the following laboratory findings: Which of the following is the most likely acid-base status?",
      "options": [
        {
          "label": "A",
          "text": "Acute respiratory acidosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic respiratory acidosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Metabolic acidosis with appropriate respiratory compensation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Mixed metabolic acidosis and respiratory acidosis",
          "correct": true
        }
      ],
      "correct_answer": "D. Mixed metabolic acidosis and respiratory acidosis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131304.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Mixed metabolic acidosis and respiratory acidosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Acute respiratory acidosis: The low bicarbonate and pH indicate metabolic involvement, which excludes isolated acute respiratory acidosis.</li><li>\u2022 Option A. Acute respiratory acidosis:</li><li>\u2022 Option B. Chronic respiratory acidosis: Chronic conditions show higher bicarbonate compensation, which is not present here.</li><li>\u2022 Option B. Chronic respiratory acidosis:</li><li>\u2022 Option C. Metabolic acidosis with appropriate respiratory compensation: The observed PCO\u2082 is much higher than predicted by Winter's formula, ruling out appropriate compensation.</li><li>\u2022 Option C. Metabolic acidosis with appropriate respiratory compensation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Winter's formula is a crucial tool to differentiate between simple and mixed acid-base disorders in metabolic acidosis. A discrepancy between observed and expected PCO\u2082 indicates an additional respiratory process.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "769cdd58",
      "audio": ""
    },
    {
      "text": "A patient has the following laboratory findings: Bicarbonate (HCO\u2083\u207b): 32 mEq/L pH: 7.51 PCO\u2082: 35 mm Hg Which of the following best describes the patient's acid-base status?",
      "options": [
        {
          "label": "A",
          "text": "Chronic respiratory alkalosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute respiratory alkalosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Metabolic alkalosis plus respiratory acidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metabolic alkalosis plus respiratory alkalosis",
          "correct": true
        }
      ],
      "correct_answer": "D. Metabolic alkalosis plus respiratory alkalosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The pH of 7.51 indicates alkalemia (alkalotic state). The elevated bicarbonate (>24 mEq/L) signifies a primary metabolic alkalosis. In metabolic alkalosis, the respiratory system typically compensates by increasing</li><li>\u2022 The pH of 7.51 indicates alkalemia (alkalotic state).</li><li>\u2022 The elevated bicarbonate (>24 mEq/L) signifies a primary metabolic alkalosis.</li><li>\u2022 In metabolic alkalosis, the respiratory system typically compensates by increasing</li><li>\u2022 PCO\u2082 to help normalize pH. But here the PCO\u2082 is 35 mm Hg (<40), which is low indicating an independent respiratory alkalosis as well.</li><li>\u2022 Whenever HCO\u2083\u207b (high in this case) and PCO2 (low in this case), move in opposite directions  it is highly suggestive of a mixed disorder.</li><li>\u2022 Whenever HCO\u2083\u207b (high in this case) and PCO2 (low in this case), move in opposite directions  it is highly suggestive of a mixed disorder.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. Chronic respiratory alkalosis : Usually presents with decreased PCO\u2082 and a compensatory decrease in bicarbonate (not elevated). The elevated bicarbonate here rules this out. Option B. Acute respiratory alkalosis : Typically involves decreased PCO\u2082 with normal bicarbonate and an elevated pH. Since bicarbonate is grossly elevated here, this does not fit. Option C. Metabolic alkalosis plus respiratory acidosis : Respiratory acidosis involves elevated PCO\u2082, but here PCO\u2082 is low, so this is incorrect.</li><li>\u2022 Option A. Chronic respiratory alkalosis : Usually presents with decreased PCO\u2082 and a compensatory decrease in bicarbonate (not elevated). The elevated bicarbonate here rules this out.</li><li>\u2022 Option A. Chronic respiratory alkalosis</li><li>\u2022 Option B. Acute respiratory alkalosis : Typically involves decreased PCO\u2082 with normal bicarbonate and an elevated pH. Since bicarbonate is grossly elevated here, this does not fit.</li><li>\u2022 Option B. Acute respiratory alkalosis</li><li>\u2022 Option C. Metabolic alkalosis plus respiratory acidosis : Respiratory acidosis involves elevated PCO\u2082, but here PCO\u2082 is low, so this is incorrect.</li><li>\u2022 Option C. Metabolic alkalosis plus respiratory acidosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When HCO\u2083\u207b and PCO\u2082 move in opposite directions\u2014it indicates a mixed acid-base disorder.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7588212d",
      "audio": ""
    },
    {
      "text": "A 65-year-old man presents with severe metabolic acidosis and the following lab results: Sodium: 140 mEq/L Chloride: 100 mEq/L Bicarbonate: 8 mEq/L BUN: 56 mg/dL Plasma Glucose: 180 mg/dL Serum Osmolality: 332 mOsm/kg Which of the following is the most likely cause of the metabolic acidosis?",
      "options": [
        {
          "label": "A",
          "text": "Methanol poisoning",
          "correct": true
        },
        {
          "label": "B",
          "text": "Diabetic ketoacidosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lactic acidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Renal failure",
          "correct": false
        }
      ],
      "correct_answer": "A. Methanol poisoning",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Methanol poisoning</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option B. Diabetic ketoacidosis: Typically presents with hyperglycemia >250 mg/dL and does not cause an elevated osmolal gap.</li><li>\u2022 Option B. Diabetic ketoacidosis:</li><li>\u2022 Option C. Lactic acidosis: Would present with elevated lactate levels, and would not present with elevated osmolal gap.</li><li>\u2022 Option C. Lactic acidosis:</li><li>\u2022 Option D. Renal failure: Causes a high anion gap metabolic acidosis due to retention of uremic toxins but does not cause an elevated osmolal gap.</li><li>\u2022 Option D. Renal failure:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cases of high anion gap metabolic acidosis with an elevated osmolal gap, toxic alcohol ingestion (e.g., methanol or ethylene glycol) should be strongly suspected. Calculate both gaps to narrow the differential diagnosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3be16abc",
      "audio": ""
    },
    {
      "text": "A 35-year-old man presents with perioral tingling and paresthesias. His blood pressure is 100/60 mm Hg. His lab results are as follows: Sodium: 142 mEq/L Chloride: 110 mEq/L Bicarbonate: 32 mEq/L Urinary chloride: 10 mEq/L What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Bartter syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gitelman syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vomiting",
          "correct": true
        },
        {
          "label": "D",
          "text": "Primary aldosteronism",
          "correct": false
        }
      ],
      "correct_answer": "C. Vomiting",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Vomiting</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Bartter syndrome: Presents with metabolic alkalosis but is associated with high urinary chloride levels (> 20 mEq/L) due to renal chloride wasting. Blood pressure is usually normal or low.</li><li>\u2022 Option A. Bartter syndrome:</li><li>\u2022 Option B. Gitelman syndrome: Also causes metabolic alkalosis with high urinary chloride levels (> 20 mEq/L). It typically includes hypomagnesemia and hypocalciuria, which are not described here.</li><li>\u2022 Option B. Gitelman syndrome:</li><li>\u2022 Option D. Primary aldosteronism: Causes metabolic alkalosis with high urinary chloride levels (> 20 mEq/L) and is associated with hypertension due to mineralocorticoid excess, which is inconsistent with this patient\u2019s low blood pressure.</li><li>\u2022 Option D. Primary aldosteronism:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Metabolic alkalosis with low urinary chloride (< 20 mEq/L) is a hallmark of chloride-responsive alkalosis , commonly caused by vomiting or diuretic use. Alkalosis-induced hypocalcemia can lead to symptoms like paresthesias and perioral tingling.</li><li>\u27a4 low urinary chloride (< 20 mEq/L)</li><li>\u27a4 chloride-responsive alkalosis</li><li>\u27a4 hypocalcemia</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9732c052",
      "audio": ""
    },
    {
      "text": "A patient presents with severe weakness and a long-standing history of dry mouth and dry eyes. His lab results are as follows: Serum Sodium (S. Na): 140 mEq/L Serum Potassium (S. K): 1.8 mEq/L Serum Chloride (S. Cl): 115 mEq/L Serum Bicarbonate (S. HCO\u2083): 12 mEq/L Urinary Sodium (Urinary Na): 25 mEq/L Urinary Potassium (Urinary K): 10 mEq/L Urinary Chloride (Urinary Cl): 20 mEq/L What is the most likely cause of the patient\u2019s condition?",
      "options": [
        {
          "label": "A",
          "text": "Proximal RTA",
          "correct": false
        },
        {
          "label": "B",
          "text": "Distal RTA",
          "correct": true
        },
        {
          "label": "C",
          "text": "Addison Disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Enterocutaneous Fistula",
          "correct": false
        }
      ],
      "correct_answer": "B. Distal RTA",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.\u00a0B) Distal RTA</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Proximal RTA: Causes bicarbonate wasting and is associated with a negative UAG. Hypokalemia is usually milder.</li><li>\u2022 Option A. Proximal RTA:</li><li>\u2022 Option C. Addison Disease: Leads to hyperkalemia due to aldosterone deficiency, which is inconsistent with the severe hypokalemia in this case.</li><li>\u2022 Option C. Addison Disease:</li><li>\u2022 Option D. Enterocutaneous Fistula: Causes bicarbonate loss leading to metabolic acidosis but is associated with a negative UAG due to increased NH\u2084\u207a excretion.</li><li>\u2022 Option D. Enterocutaneous Fistula:</li><li>\u2022 negative UAG</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A positive urinary anion gap in the context of normal anion gap metabolic acidosis indicates impaired renal ammonium excretion, a hallmark of distal RTA . This is a key differentiating feature from gastrointestinal bicarbonate losses, which present with a negative UAG. Recognizing these patterns helps narrow the differential diagnosis.</li><li>\u27a4 distal RTA</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c7bcf19f",
      "audio": ""
    },
    {
      "text": "A 61-year-old man presents with worsening fever, cough, and dyspnea for the past 2 days. He was started on empirical azithromycin 3 days ago, but his condition has worsened. ABG and lab results are as follows: What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute exacerbation of COPD",
          "correct": true
        },
        {
          "label": "B",
          "text": "Chronic respiratory acidosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acute respiratory acidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pulmonary embolism",
          "correct": false
        }
      ],
      "correct_answer": "A. Acute exacerbation of COPD",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131403.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Acute exacerbation of COPD</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option B. Chronic respiratory acidosis: Chronic respiratory acidosis is expected in stable COPD patients with compensated hypercapnia. However, the low pH in this patient indicates an acute decompensation.</li><li>\u2022 Option B. Chronic respiratory acidosis:</li><li>\u2022 Option C. Acute respiratory acidosis: Pure acute respiratory acidosis would not explain the elevated bicarbonate, which reflects chronic compensation in COPD.</li><li>\u2022 Option C. Acute respiratory acidosis:</li><li>\u2022 Option D. Pulmonary embolism: Pulmonary embolism typically causes respiratory alkalosis due to hyperventilation, with low pCO\u2082 levels, not the hypercapnia seen here.</li><li>\u2022 Option D. Pulmonary embolism:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In a patient with known COPD, a low pH with elevated pCO\u2082 and bicarbonate indicates acute respiratory acidosis superimposed on chronic compensation, suggesting acute exacerbation of COPD (AECOPD) . Prompt recognition and treatment of the underlying cause, such as infection, are critical.</li><li>\u27a4 acute exacerbation of COPD (AECOPD)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "10f72f73",
      "audio": ""
    },
    {
      "text": "A 24-year-old pregnant woman (30 weeks gestation) has been diagnosed with pneumonia. She is currently receiving high-flow oxygen with an FiO\u2082 of 0.5. Her ABG and lab results are as follows: pH: 7.42 pCO\u2082: 29 mmHg HCO\u2083\u207b: 20 mmol/L Base Excess: -5.1 mmol/L pO\u2082: 123 mmHg O\u2082 Saturation: 99% Potassium: 3.0 mmol/L Sodium: 133 mmol/L Chloride: 109 mmol/L What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute respiratory distress syndrome (ARDS)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Type 1 respiratory failure",
          "correct": true
        },
        {
          "label": "C",
          "text": "Alveolar hypoventilation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Type 4 respiratory failure",
          "correct": false
        }
      ],
      "correct_answer": "B. Type 1 respiratory failure",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Type 1 respiratory failure</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Acute respiratory distress syndrome (ARDS): While ARDS can cause Type 1 respiratory failure, it typically presents with severe hypoxemia and bilateral infiltrates, and patients would not respond to 100% O2 due to significant shunting.</li><li>\u2022 Option A.</li><li>\u2022 Acute respiratory distress syndrome (ARDS):</li><li>\u2022 Option C. Alveolar hypoventilation: This condition leads to hypercapnia (elevated pCO\u2082), which is not present in this patient.</li><li>\u2022 Option C.</li><li>\u2022 Alveolar hypoventilation:</li><li>\u2022 Option D. Type 4 respiratory failure: Type 4 failure refers to hypoperfusion due to circulatory failure (e.g., septic shock), which is not indicated by the patient's ABG or clinical scenario.</li><li>\u2022 Option D.</li><li>\u2022 Type 4 respiratory failure:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Type 1 respiratory failure is characterized by hypoxemia with a normal or low pCO\u2082 and is caused by V/Q mismatch, diffusion limitation, or shunting. An elevated A-a gradient with a good response to supplemental oxygen suggests V/Q mismatch, commonly seen in pneumonia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7fdf2343",
      "audio": ""
    },
    {
      "text": "A 50-year-old man with a history of alcohol use disorder presents with confusion and abdominal pain. His lab results are as follows: Sodium: 138 mEq/L Chloride: 102 mEq/L Bicarbonate: 12 mEq/L Blood glucose: 100 mg/dL Lactate: 3 mmol/L Serum osmolality: 350 mOsm/kg Ethanol level: Undetectable Urinary oxalate crystals: Present What is the most likely cause of his high anion gap metabolic acidosis?",
      "options": [
        {
          "label": "A",
          "text": "Methanol poisoning",
          "correct": false
        },
        {
          "label": "B",
          "text": "Diabetic ketoacidosis (DKA)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ethylene glycol poisoning",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lactic acidosis",
          "correct": false
        }
      ],
      "correct_answer": "C. Ethylene glycol poisoning",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Ethylene glycol poisoning</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Methanol poisoning: Methanol poisoning causes high anion gap metabolic acidosis but typically presents with visual symptoms due to formate toxicity.</li><li>\u2022 Option A.</li><li>\u2022 Methanol poisoning:</li><li>\u2022 Option B. Diabetic ketoacidosis (DKA): DKA causes high anion gap metabolic acidosis with elevated glucose, which is not present here.</li><li>\u2022 Option B.</li><li>\u2022 Diabetic ketoacidosis (DKA):</li><li>\u2022 Option D. Lactic acidosis: Lactate is mildly elevated but not high enough to explain the metabolic acidosis.</li><li>\u2022 Option D.</li><li>\u2022 Lactic acidosis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Suspect ethylene glycol poisoning in high anion gap metabolic acidosis with urinary oxalate crystals and an elevated osmolality gap.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a5b8b12a",
      "audio": ""
    },
    {
      "text": "A 55-year-old man presents with a history of chronic obstructive pulmonary disease (COPD). His ABG results show the following: pH: 7.37 pCO\u2082: 55 mmHg HCO\u2083\u207b: 32 mEq/L Using the marked image, identify the most likely area (A-G) on the ABG nomogram corresponding to his clinical picture.",
      "options": [
        {
          "label": "A",
          "text": "A",
          "correct": false
        },
        {
          "label": "B",
          "text": "B",
          "correct": true
        },
        {
          "label": "C",
          "text": "F",
          "correct": false
        },
        {
          "label": "D",
          "text": "G",
          "correct": false
        }
      ],
      "correct_answer": "B. B",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131514.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131531.jpg"
      ],
      "explanation": "<p><strong>Ans. B) B</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. A corresponds to a normal ABG, which does not match the patient's elevated pCO\u2082 and HCO\u2083\u207b values.</li><li>\u2022 Option A. A</li><li>\u2022 Option C. F represents acute metabolic acidosis, where pH would be significantly lower without compensatory bicarbonate elevation.</li><li>\u2022 Option C. F</li><li>\u2022 Option D. G represents metabolic acidosis with hyperchloremia or renal tubular acidosis, which does not fit this patient's findings.</li><li>\u2022 Option D. G</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Understand the interpretation of ABG values in relation to the ABG nomogram and their clinical significance in chronic respiratory acidosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "96ef607b",
      "audio": ""
    },
    {
      "text": "Using the marked ABG nomogram, identify the area D.",
      "options": [
        {
          "label": "A",
          "text": "Acute respiratory alkalosis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Metabolic alkalosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chronic respiratory alkalosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Normal ABG",
          "correct": false
        }
      ],
      "correct_answer": "A. Acute respiratory alkalosis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131553.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131617.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Acute respiratory alkalosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option B. Metabolic alkalosis : Is associated with increased bicarbonate levels and compensatory respiratory changes, which do aligns with the region C on the given image.</li><li>\u2022 Option B. Metabolic alkalosis</li><li>\u2022 Option C. Chronic respiratory alkalosis : Would align with the region E on the given image.</li><li>\u2022 Option C. Chronic respiratory alkalosis</li><li>\u2022 Option D. Normal ABG: Values would fall within the central region (marked as A), not D.</li><li>\u2022 Option D. Normal ABG:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Use the ABG nomogram to identify and interpret patterns of acid-base disturbances, specifically differentiating acute from chronic respiratory and metabolic conditions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "02209d07",
      "audio": ""
    },
    {
      "text": "A 55-year-old patient with long-standing type 2 diabetes presents with fatigue, pruritus, and elevated creatinine. Renal ultrasound shows bilaterally small kidneys measuring 7 cm in length. Which of the following laboratory findings would best support a diagnosis of CKD rather than acute kidney injury (AKI)?",
      "options": [
        {
          "label": "A",
          "text": "Elevated serum creatinine kinase (CK)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypercalcemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Elevated parathyroid hormone (PTH)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hypokalemia",
          "correct": false
        }
      ],
      "correct_answer": "C. Elevated parathyroid hormone (PTH)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Elevated parathyroid hormone (PTH)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Elevated serum creatinine kinase (CK) : Elevated CK is primarily seen in muscle damage, not CKD.</li><li>\u2022 Option A. Elevated serum creatinine kinase (CK)</li><li>\u2022 Option B. Hypercalcemia : CKD often leads to hypocalcemia (low calcium) due to impaired vitamin D metabolism, not hypercalcemia.</li><li>\u2022 Option B. Hypercalcemia</li><li>\u2022 Option D. Hypokalemia : Hypokalemia is not a primary feature of CKD, although it can occur in later stages due to medication use or other factors.</li><li>\u2022 Option D. Hypokalemia</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 CKD is characterized by a gradual decline in kidney function over months or years, while AKI is a sudden onset of kidney dysfunction. Elevated parathyroid hormone (PTH) is a key laboratory marker for CKD due to secondary hyperparathyroidism caused by impaired vitamin D metabolism and phosphate retention.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "05586fdf",
      "audio": ""
    },
    {
      "text": "Which of the following clinical presentations would further support a diagnosis of chronic kidney disease (CKD) rather than acute kidney injury (AKI)?",
      "options": [
        {
          "label": "A",
          "text": "Sudden onset of flank pain and hematuria",
          "correct": false
        },
        {
          "label": "B",
          "text": "History of recent contrast dye exposure",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hyperkalemia and metabolic acidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Progressive worsening of anemia over several months",
          "correct": true
        }
      ],
      "correct_answer": "D. Progressive worsening of anemia over several months",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Progressive worsening of anemia over several months</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Sudden onset of flank pain and hematuria : This presentation is more suggestive of an acute process, such as kidney stones or a urinary tract infection.</li><li>\u2022 Option A. Sudden onset of flank pain and hematuria</li><li>\u2022 Option B. History of recent contrast dye exposure : Contrast-induced nephropathy is an acute kidney injury that typically occurs within a few days of exposure to contrast dye.</li><li>\u2022 Option B. History of recent contrast dye exposure</li><li>\u2022 Option C. Hyperkalemia and metabolic acidosis : While these electrolyte imbalances can occur in both AKI and CKD, they are more commonly associated with acute renal failure due to the rapid decline in kidney function.</li><li>\u2022 Option C. Hyperkalemia and metabolic acidosis</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 CKD typically presents with a gradual onset of symptoms such as fatigue, edema, and foamy urine, along with progressive anemia due to reduced erythropoietin production. In contrast, AKI presents with a sudden onset of symptoms like flank pain, hematuria, or recent exposure to nephrotoxic agents.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6fa6a464",
      "audio": ""
    },
    {
      "text": "A 70-year-old man with a history of hypertension presents with acute onset oliguria and elevated creatinine. His blood pressure is 90/60 mmHg, and he reports recent episodes of diarrhea and vomiting. Which of the following is the most likely cause of his AKI?",
      "options": [
        {
          "label": "A",
          "text": "Acute tubular necrosis (ATN)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Prerenal azotemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Acute interstitial nephritis (AIN)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Postrenal obstruction",
          "correct": false
        }
      ],
      "correct_answer": "B. Prerenal azotemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Prerenal azotemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Acute tubular necrosis (ATN): While possible, it's less likely in this scenario without a history of nephrotoxic drug exposure or prolonged hypotension</li><li>\u2022 Option A.</li><li>\u2022 Acute tubular necrosis (ATN):</li><li>\u2022 Option C. Acute interstitial nephritis (AIN): This would typically present with fever, rash, or other signs of allergic reaction.</li><li>\u2022 Option C.</li><li>\u2022 Acute interstitial nephritis (AIN):</li><li>\u2022 Option D. Postrenal obstruction: Less likely given the absence of urinary symptoms suggestive of obstruction</li><li>\u2022 Option D.</li><li>\u2022 Postrenal obstruction:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the different causes of acute kidney injury (AKI) and to be able to identify prerenal azotemia as the most likely cause in a patient with hypotension, dehydration, and oliguria. Prerenal azotemia is a functional AKI caused by decreased blood flow to the kidneys, often due to volume depletion or low blood pressure.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "65d86f21",
      "audio": ""
    },
    {
      "text": "A 65-year-old male with a history of heart failure and diabetes mellitus is admitted to the hospital with worsening shortness of breath and leg edema. His serum creatinine has increased from 1.2 mg/dL to 2.5 mg/dL over the past 2 days. Which of the following medications is most likely to have precipitated this acute kidney injury?",
      "options": [
        {
          "label": "A",
          "text": "Metformin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Furosemide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lisinopril",
          "correct": true
        },
        {
          "label": "D",
          "text": "Aspirin",
          "correct": false
        }
      ],
      "correct_answer": "C. Lisinopril",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Lisinopril</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Metformin : Metformin is not directly nephrotoxic but can cause lactic acidosis, which can worsen AKI.</li><li>\u2022 Option A. Metformin</li><li>\u2022 Option B. Furosemide : Furosemide, a diuretic, might worsen AKI if dehydration is the underlying cause.</li><li>\u2022 Option B.</li><li>\u2022 Furosemide</li><li>\u2022 Option D. Aspirin : Aspirin is not typically associated with AKI unless taken in very high doses.</li><li>\u2022 Option D. Aspirin</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize that angiotensin-converting enzyme (ACE) inhibitors, such as lisinopril, can precipitate acute kidney injury (AKI) in patients with pre-existing cardiac or renal dysfunction. ACE inhibitors can decrease glomerular filtration rate (GFR) by reducing efferent arteriolar resistance, particularly in patients with decreased renal perfusion.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4c2de28f",
      "audio": ""
    },
    {
      "text": "Which of the following scenarios would classify a patient as having Stage 3 AKI?",
      "options": [
        {
          "label": "A",
          "text": "A 40-year-old with baseline creatinine of 1.2 mg/dL, current creatinine of 2.6 mg/dL, and urine output of 0.4 mL/kg/hour for 18 hours.",
          "correct": false
        },
        {
          "label": "B",
          "text": "A 25-year-old with a baseline creatinine of 0.9 mg/dL, current creatinine of 1.8 mg/dL, and anuria for 14 hours.",
          "correct": false
        },
        {
          "label": "C",
          "text": "A 50-year-old with a baseline creatinine of 0.9 mg/dL, current creatinine of 1.5 mg/dL, and anuria for 10 hours.",
          "correct": false
        },
        {
          "label": "D",
          "text": "A 15-year-old with a decrease in eGFR to 30 mL/min/1.73 m\u00b2.",
          "correct": true
        }
      ],
      "correct_answer": "D. A 15-year-old with a decrease in eGFR to 30 mL/min/1.73 m\u00b2.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-144229.png"
      ],
      "explanation": "<p><strong>Ans. D) A 15-year-old with a decrease in eGFR to 30 mL/min/1.73 m\u00b2.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c5d3fb46",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman with a history of diabetes mellitus presents with nausea, vomiting, and oliguria. Her serum creatinine is 2.5 mg/dL, and her urine microscopy shows muddy brown granular casts. Which of the following biomarkers would be most helpful in confirming the diagnosis of acute tubular necrosis (ATN)?",
      "options": [
        {
          "label": "A",
          "text": "Plasma NGAL",
          "correct": false
        },
        {
          "label": "B",
          "text": "Urinary KIM-1",
          "correct": true
        },
        {
          "label": "C",
          "text": "Plasma suPAR",
          "correct": false
        },
        {
          "label": "D",
          "text": "Urinary TIMP-2 and IGFBP7",
          "correct": false
        }
      ],
      "correct_answer": "B. Urinary KIM-1",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Urinary KIM-1</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Plasma NGAL : While NGAL is an early marker for AKI, it's not specific for ATN and can be elevated in other causes of kidney injury.</li><li>\u2022 Option A. Plasma NGAL</li><li>\u2022 Option C. Plasma suPAR : suPAR is more useful in predicting the risk of developing AKI, not confirming ATN.</li><li>\u2022 Option C. Plasma suPAR</li><li>\u2022 Option D. Urinary TIMP-2 and IGFBP7 : These biomarkers are primarily used to predict the risk of severe AKI, not to diagnose the specific cause like ATN</li><li>\u2022 Option D. Urinary TIMP-2 and IGFBP7</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the role of urinary biomarkers, specifically KIM-1, in confirming the diagnosis of acute tubular necrosis (ATN). ATN is a common cause of acute kidney injury (AKI), characterized by damage to the renal tubules. Urinary KIM-1 is a highly sensitive and specific biomarker for ATN, as it is released from injured proximal tubular cells.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "51009a38",
      "audio": ""
    },
    {
      "text": "A 65-year-old woman with a history of recurrent urinary tract infections presents with fever, chills, flank pain, and anuria. Ultrasound reveals bilateral hydronephrosis. Which of the following is the most appropriate next step in management?",
      "options": [
        {
          "label": "A",
          "text": "Antibiotics alone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Intravenous fluids and observation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Percutaneous nephrostomy tube placement",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ureteral stent placement",
          "correct": false
        }
      ],
      "correct_answer": "C. Percutaneous nephrostomy tube placement",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Percutaneous nephrostomy tube placement</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Antibiotics alone : Antibiotics alone will not address the underlying obstruction causing the anuria and potential kidney damage.</li><li>\u2022 Option A. Antibiotics alone</li><li>\u2022 Option B. Intravenous fluids and observation : Intravenous fluids may worsen hydronephrosis and observation is not appropriate in the setting of anuria.</li><li>\u2022 Option B. Intravenous fluids and observation</li><li>\u2022 Option D. Ureteral stent placement : Ureteral stent placement, while a possible treatment, is not as immediate or effective as nephrostomy in relieving anuria</li><li>\u2022 Option D. Ureteral stent placement</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Obstructive uropathy can quickly lead to irreversible kidney damage, and immediate intervention with a percutaneous nephrostomy tube is often necessary to preserve renal function.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "657417d1",
      "audio": ""
    },
    {
      "text": "A 60-year-old patient with no prior kidney disease undergoes elective abdominal aortic aneurysm repair requiring cross-clamping of the aorta above the renal arteries. The procedure lasts 45 minutes, and the patient's blood pressure is well-maintained throughout. Which of the following statements regarding the patient's risk of acute kidney injury (AKI) is most accurate?",
      "options": [
        {
          "label": "A",
          "text": "The patient is at high risk of developing severe AKI requiring dialysis.",
          "correct": false
        },
        {
          "label": "B",
          "text": "The patient is at moderate risk of AKI, and close monitoring of renal function is necessary.",
          "correct": false
        },
        {
          "label": "C",
          "text": "The patient is at low risk of severe AKI, as transient ischemia in a normal kidney is unlikely to cause significant damage.",
          "correct": true
        },
        {
          "label": "D",
          "text": "The patient's risk of AKI cannot be determined without knowing their baseline creatinine level.",
          "correct": false
        }
      ],
      "correct_answer": "C. The patient is at low risk of severe AKI, as transient ischemia in a normal kidney is unlikely to cause significant damage.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) The patient is at low risk of severe AKI, as transient ischemia in a normal kidney is unlikely to cause significant damage.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. The patient is at high risk of developing severe AKI requiring dialysis : Severe AKI requiring dialysis is unlikely after a brief, well-managed ischemic event in a healthy individual.</li><li>\u2022 Option A. The patient is at high risk of developing severe AKI requiring dialysis</li><li>\u2022 Option B. The patient is at moderate risk of AKI, and close monitoring of renal function is necessary : While some degree of AKI is possible, it is unlikely to be moderate in this specific scenario with a normal kidney and controlled blood pressure.</li><li>\u2022 Option B. The patient is at moderate risk of AKI, and close monitoring of renal function is necessary</li><li>\u2022 Option D. The patient's risk of AKI cannot be determined without knowing their baseline creatinine level : While baseline creatinine is helpful, the focus here is the effect of transient ischemia on a normal kidney, not the pre-existing renal function.</li><li>\u2022 Option D. The patient's risk of AKI cannot be determined without knowing their baseline creatinine level</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Factors like adequate blood supply, autoregulation mechanisms, and cellular repair processes contribute to the kidney's resilience to transient ischemic events.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b8db5fd4",
      "audio": ""
    },
    {
      "text": "A 70-year-old male with a history of chronic heart failure (CHF) on furosemide presents with worsening dyspnea, oliguria, hypotension, and elevated serum creatinine and blood urea nitrogen (BUN) levels. Urinalysis demonstrates dilute urine. The treating physician is suspecting Pre-renal AKI rather than a ATN, which of the following findings supports his diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "FeNa < 1%",
          "correct": true
        },
        {
          "label": "B",
          "text": "FeNa 1-2%",
          "correct": false
        },
        {
          "label": "C",
          "text": "FeNa 2-3%",
          "correct": false
        },
        {
          "label": "D",
          "text": "FeNa > 3%",
          "correct": false
        }
      ],
      "correct_answer": "A. FeNa < 1%",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) FeNa < 1%</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. FeNa 1-2%: This is an indeterminate FeNa range, not definitively diagnostic of either prerenal AKI or ATN.</li><li>\u2022 Option B. FeNa 1-2%:</li><li>\u2022 Option C. FeNa 2-3%: This value suggests intrinsic renal injury, more characteristic of ATN where the tubules are unable to effectively reabsorb sodium.</li><li>\u2022 Option C. FeNa 2-3%:</li><li>\u2022 Option D. FeNa > 3%: A FeNa greater than 3% strongly suggests intrinsic renal injury, likely ATN, where the tubules have lost their reabsorptive capacity.</li><li>\u2022 Option D. FeNa > 3%:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 A low FeNa (<1%) is a hallmark of prerenal AKI, reflecting the kidney's attempt to conserve sodium in response to decreased renal perfusion.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0e78edc4",
      "audio": ""
    },
    {
      "text": "Which of the following medications has been shown to potentially prevent AKI in patients with cirrhosis and spontaneous bacterial peritonitis treated with antibiotics?",
      "options": [
        {
          "label": "A",
          "text": "Terlipressin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Octreotide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Midodrine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Albumin",
          "correct": true
        }
      ],
      "correct_answer": "D. Albumin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Albumin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Terlipressin : Terlipressin works by constricting blood vessels in the splanchnic circulation, which can improve blood flow to the kidneys.</li><li>\u2022 Option A. Terlipressin</li><li>\u2022 Option B. Octreotide : Octreotide reduces splanchnic blood flow and inhibits the release of hormones that worsen kidney function.</li><li>\u2022 Option B. Octreotide</li><li>\u2022 Option D. Midodrine : Midodrine is a vasopressor that helps to increase blood pressure and improve renal perfusion.</li><li>\u2022 Option D. Midodrine</li><li>\u2022 While these medications may indirectly improve kidney function in some patients, they are not the first-line therapy for preventing AKI in SBP. Albumin administration, on the other hand, has been shown to be more effective in this specific context.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand that albumin administration is an effective intervention for preventing acute kidney injury (AKI) in patients with cirrhosis and spontaneous bacterial peritonitis (SBP) treated with antibiotics. Albumin helps improve renal perfusion and reduce inflammation, thereby mitigating the risk of AKI in this specific population.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "467651ee",
      "audio": ""
    },
    {
      "text": "A 58-year-old patient with decompensated cirrhosis and refractory ascites presents with oliguria, worsening creatinine, and a low urine sodium concentration (<10 mEq/L). Despite aggressive volume resuscitation with albumin, their renal function continues to decline. Which of the following represents the definitive treatment for their underlying condition?",
      "options": [
        {
          "label": "A",
          "text": "Terlipressin and albumin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Octreotide and midodrine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Continuous renal replacement therapy (CRRT)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Liver transplantation",
          "correct": true
        }
      ],
      "correct_answer": "D. Liver transplantation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Liver transplantation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Terlipressin and albumin: These are vasoconstrictor medications used as a bridge to transplant in HRS, providing temporary improvement in renal function.</li><li>\u2022 Option A. Terlipressin and albumin:</li><li>\u2022 Option B. Octreotide and midodrine: This combination is another pharmacologic therapy used to manage HRS, but it doesn't address the root cause.</li><li>\u2022 Option B. Octreotide and midodrine:</li><li>\u2022 Option C. Continuous renal replacement therapy (CRRT): While CRRT can provide temporary support for kidney function, it does not treat the underlying cause of HRS and is not a definitive treatment.</li><li>\u2022 Option C. Continuous renal replacement therapy (CRRT):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize that liver transplantation is the definitive treatment for hepatorenal syndrome (HRS), a serious complication of advanced cirrhosis characterized by renal failure. While pharmacological interventions like terlipressin, albumin, octreotide, and midodrine can provide temporary support, they do not address the underlying liver dysfunction that drives HRS.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7f363dc7",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a proposed mechanism for the cardiorenal syndrome in ADHF?",
      "options": [
        {
          "label": "A",
          "text": "Reduced renal perfusion due to low cardiac output",
          "correct": true
        },
        {
          "label": "B",
          "text": "Increased venous congestion leading to renal venous hypertension",
          "correct": false
        },
        {
          "label": "C",
          "text": "Neurohormonal activation (RAAS, SNS)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Direct nephrotoxicity of heart failure medications.",
          "correct": false
        }
      ],
      "correct_answer": "A. Reduced renal perfusion due to low cardiac output",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Reduced renal perfusion due to low cardiac output.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Increased venous congestion leading to renal venous hypertension: In ADHF, the heart's reduced pumping capacity can lead to a backup of blood in the veins, including those draining the kidneys. This increased pressure can impede blood flow through the kidneys, leading to decreased glomerular filtration rate (GFR) and contributing to CRS.</li><li>\u2022 Option B. Increased venous congestion leading to renal venous hypertension:</li><li>\u2022 Option C. Neurohormonal activation (RAAS, SNS): In response to decreased cardiac output, the body activates neurohormonal systems like the renin-angiotensin-aldosterone system (RAAS) and the sympathetic nervous system (SNS). These systems can cause vasoconstriction in the kidneys, further reducing blood flow and contributing to renal dysfunction.</li><li>\u2022 Option C. Neurohormonal activation (RAAS, SNS):</li><li>\u2022 Option D. Direct nephrotoxicity of heart failure medications: Some medications used to treat heart failure, such as certain diuretics and NSAIDs, can be directly toxic to the kidneys, especially in patients with pre-existing renal dysfunction. This can worsen or precipitate AKI in the context of CRS.</li><li>\u2022 Option D. Direct nephrotoxicity of heart failure medications:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the pathophysiology of cardiorenal syndrome (CRS) in acute decompensated heart failure (ADHF), recognizing that reduced renal perfusion due to low cardiac output is NOT a primary mechanism in most cases. Instead, venous congestion, neurohormonal activation, and direct nephrotoxicity of medications are the main contributors to this complex syndrome.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5db90115",
      "audio": ""
    },
    {
      "text": "A patient with stage 4 CKD on dialysis develops nephrogenic systemic fibrosis (NSF) after an MRI. Which contrast agent was most likely used?",
      "options": [
        {
          "label": "A",
          "text": "Gadolinium-based contrast agent (GBCA)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Iodine-based contrast agent",
          "correct": false
        },
        {
          "label": "C",
          "text": "Barium sulfate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Air contrast",
          "correct": false
        }
      ],
      "correct_answer": "A. Gadolinium-based contrast agent (GBCA)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Gadolinium-based contrast agent (GBCA)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Iodine- based contrast agents: These are primarily used in X-ray and CT imaging. While they can cause contrast-induced nephropathy (CIN), they are not associated with nephrogenic systemic fibrosis (NSF).</li><li>\u2022 Option B. Iodine-</li><li>\u2022 based contrast agents:</li><li>\u2022 Option C. Barium sulfate: This contrast agent is used for gastrointestinal imaging and is not typically administered intravenously. Thus, it would not be expected to cause NSF, which is related to systemic exposure to contrast agents.</li><li>\u2022 Option C. Barium</li><li>\u2022 sulfate:</li><li>\u2022 Option D. Air contrast : This is not a chemical contrast agent, but rather air or carbon dioxide used to enhance the visibility of certain structures in imaging studies. It does not pose a risk of NSF</li><li>\u2022 Option D. Air contrast</li><li>\u2022 :</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the association between gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF) in patients with advanced kidney disease. Recognizing that GBCA exposure is the primary risk factor for NSF is crucial for preventing this debilitating condition.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a23c4464",
      "audio": ""
    },
    {
      "text": "A 65-year-old diabetic patient with chronic kidney disease (eGFR 35 mL/min) is scheduled for a coronary angiogram. Which of the following measures is most likely to prevent contrast-induced nephropathy (CIN)?",
      "options": [
        {
          "label": "A",
          "text": "Administer high-dose furosemide before and after the procedure.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Use low-osmolar or iso-osmolar contrast media.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pretreat with oral N-acetylcysteine.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hold metformin for 48 hours before and after the procedure.",
          "correct": false
        }
      ],
      "correct_answer": "B. Use low-osmolar or iso-osmolar contrast media.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Use low-osmolar or iso-osmolar contrast media.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Administer high-dose furosemide before and after the procedure : Furosemide may actually worsen renal function in this setting.</li><li>\u2022 Option A. Administer high-dose furosemide before and after the procedure</li><li>\u2022 Option C. Pretreat with oral N-acetylcysteine : N-acetylcysteine has limited evidence for CIN prevention.</li><li>\u2022 Option C. Pretreat with oral N-acetylcysteine</li><li>\u2022 Option D. Hold metformin for 48 hours before and after the procedure : Metformin is held due to lactic acidosis risk, not CIN.</li><li>\u2022 Option D. Hold metformin for 48 hours before and after the procedure</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize the importance of using low-osmolar or iso-osmolar contrast media in patients with chronic kidney disease (CKD) to prevent contrast-induced nephropathy (CIN). While other measures like hydration and withholding certain medications are also important, the choice of contrast agent plays a significant role in mitigating the risk of CIN in these patients.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6c13eaa1",
      "audio": ""
    },
    {
      "text": "A 72-year-old man presents with livedo reticularis, blue toes, and acute kidney injury (AKI) after undergoing a coronary angiogram. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute interstitial nephritis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Contrast-induced nephropathy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Atheroembolic renal disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cholesterol emboli syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. Atheroembolic renal disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Atheroembolic renal disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Acute interstitial nephritis : AIN is not associated with livedo reticularis or blue toes.</li><li>\u2022 Option A. Acute interstitial nephritis</li><li>\u2022 Option B. Contrast-induced nephropathy : CIN typically presents within 24-48 hours of contrast exposure, not days later.</li><li>\u2022 Option B. Contrast-induced nephropathy</li><li>\u2022 Option D. Cholesterol emboli syndrome : While similar, cholesterol emboli syndrome typically lacks renal involvement</li><li>\u2022 Option D. Cholesterol emboli syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize the classic presentation of atheroembolic renal disease (AERD), which includes livedo reticularis, blue toes (cyanosis), and acute kidney injury (AKI) following a vascular procedure. This triad of symptoms is highly suggestive of AERD and should prompt further investigation and appropriate management.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "aacbd58c",
      "audio": ""
    },
    {
      "text": "A patient with rhabdomyolysis develops acute kidney injury (AKI). Which of the following is the most likely mechanism of AKI in this setting?",
      "options": [
        {
          "label": "A",
          "text": "Immune-mediated glomerulonephritis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Renal artery stenosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Renal tubular obstruction by myoglobin casts",
          "correct": true
        },
        {
          "label": "D",
          "text": "Crystal nephropathy",
          "correct": false
        }
      ],
      "correct_answer": "C. Renal tubular obstruction by myoglobin casts",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Renal tubular obstruction by myoglobin casts</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Immune-mediated glomerulonephritis: This is an inflammatory process affecting the glomeruli (filtering units of the kidney) and is not the primary mechanism in rhabdomyolysis-induced AKI.</li><li>\u2022 Option A. Immune-mediated glomerulonephritis:</li><li>\u2022 Option B. Renal artery stenosis: This is a narrowing of the artery supplying the kidney, which can reduce blood flow and cause kidney damage, but it is not directly related to rhabdomyolysis.</li><li>\u2022 Option B. Renal artery stenosis:</li><li>\u2022 Option D. Crystal nephropathy: This is caused by the deposition of crystals in the kidneys, most commonly from medications like acyclovir or sulfa drugs, and is not the primary mechanism in rhabdomyolysis.</li><li>\u2022 Option D. Crystal nephropathy:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 The pathophysiology of acute kidney injury (AKI) in rhabdomyolysis, specifically recognizing that renal tubular obstruction by myoglobin casts is the primary mechanism.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "04e10f43",
      "audio": ""
    },
    {
      "text": "Which of the following medications is known to increase the risk of rhabdomyolysis?",
      "options": [
        {
          "label": "A",
          "text": "Statins",
          "correct": false
        },
        {
          "label": "B",
          "text": "Amphetamines",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cocaine",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) All of the above</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d5a1a3b9",
      "audio": ""
    },
    {
      "text": "A 50-year-old patient presents with acute kidney injury (AKI), fever, maculopapular rash, and arthralgias after recently starting a new medication. A renal biopsy is performed. Which of the following HPE findings will be seen in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Glomerular crescent formation and fibrinoid necrosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tubular atrophy and interstitial fibrosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Interstitial edema and inflammatory infiltrate with predominantly eosinophils",
          "correct": true
        },
        {
          "label": "D",
          "text": "Thickening of the glomerular basement membrane with immune complex deposits",
          "correct": false
        }
      ],
      "correct_answer": "C. Interstitial edema and inflammatory infiltrate with predominantly eosinophils",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Interstitial edema and inflammatory infiltrate with predominantly eosinophils</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Glomerular crescent formation and fibrinoid necrosis: These are characteristic of rapidly progressive glomerulonephritis (RPGN), a different type of kidney disease.</li><li>\u2022 Option A. Glomerular crescent formation and fibrinoid necrosis:</li><li>\u2022 Option B. Tubular atrophy and interstitial fibrosis: These findings are more indicative of chronic kidney disease (CKD) rather than the acute inflammatory process of AIN.</li><li>\u2022 Option B. Tubular atrophy and interstitial fibrosis:</li><li>\u2022 Option D. Thickening of the glomerular basement membrane with immune complex deposits: This is a common feature of immune-complex mediated glomerulonephritis, not AIN.</li><li>\u2022 Option D. Thickening of the glomerular basement membrane with immune complex deposits:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 The characteristic histopathological features of acute interstitial nephritis (AIN) on a renal biopsy, which include interstitial edema, inflammatory infiltrate with predominantly eosinophils, and tubulitis. Recognizing these findings is crucial for the accurate diagnosis and management of AIN, a common cause of acute kidney injury (AKI).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a4612f0b",
      "audio": ""
    },
    {
      "text": "A 25-year-old female presents to the emergency department with fever, flank pain, and dysuria. Urinalysis is performed as part of her evaluation, which is shown in the image. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute glomerulonephritis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pyelonephritis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Acute Interstitial Nephritis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acute tubular necrosis",
          "correct": false
        }
      ],
      "correct_answer": "B. Pyelonephritis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-150231.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Pyelonephritis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Acute glomerulonephritis : Acute glomerulonephritis is usually characterized by hypertension, hematuria with red blood cell casts, proteinuria, and varying degrees of renal insufficiency, which is not consistent with the presented findings.</li><li>\u2022 Option</li><li>\u2022 A. Acute glomerulonephritis</li><li>\u2022 Option C. Acute interstitial nephritis : Acute interstitial nephritis typically presents with a rash, fever, and eosinophilia and is often a hypersensitivity reaction to medications. WBC casts may be present, but the clinical symptoms and the absence of medication history make this less likely.</li><li>\u2022 Option</li><li>\u2022 C. Acute interstitial nephritis</li><li>\u2022 Option D. Acute tubular necrosis (ATN) : Acute tubular necrosis (ATN) often presents with a history of ischemia or nephrotoxic injury, and the urinalysis would typically show muddy brown casts, not the white blood cell casts indicative of infection.</li><li>\u2022 Option</li><li>\u2022 D. Acute tubular necrosis (ATN)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Pyelonephritis is diagnosed based on the combination of clinical symptoms such as fever, flank pain, and dysuria, along with laboratory findings of white blood cell casts in the urine, indicating an infection that has reached the renal pelvis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7cd889d9",
      "audio": ""
    },
    {
      "text": "A 72-year-old male with hypertension and type 2 diabetes presents with oliguria, weakness, nausea, and recent initiation of a new anti-hypertensive medication. He has elevated creatinine, BUN, and hyperkalemia. Urinalysis slide is shown below. What\u2019s the most likely cause of his kidney injury?",
      "options": [
        {
          "label": "A",
          "text": "Prerenal azotemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute tubular necrosis (ATN)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Acute glomerulonephritis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Postrenal obstruction",
          "correct": false
        }
      ],
      "correct_answer": "B. Acute tubular necrosis (ATN)",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-150358.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Acute tubular necrosis (ATN)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Prerenal azotemia: While possible given the patient's history, prerenal AKI usually presents with bland urine sediment and a BUN/creatinine ratio >20:1. The presence of granular casts makes this diagnosis less likely.</li><li>\u2022 Option A. Prerenal azotemia:</li><li>\u2022 Option C. Acute glomerulonephritis: This typically presents with hematuria, proteinuria, and RBC casts. The absence of these findings and the presence of granular casts make this diagnosis less likely.</li><li>\u2022 Option C. Acute glomerulonephritis:</li><li>\u2022 Option D. Postrenal obstruction: This would likely present with anuria and pain. Ultrasound would be needed to confirm this diagnosis. The presence of granular casts points toward intrinsic renal injury rather than obstruction.</li><li>\u2022 Option D. Postrenal obstruction:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The characteristic findings of acute tubular necrosis (ATN) on urinalysis, which include muddy brown granular casts. These casts, in combination with the patient's clinical presentation and history (recent medication change, elevated creatinine, BUN, and hyperkalemia), can help distinguish ATN from other causes of acute kidney injury (AKI).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "95838623",
      "audio": ""
    },
    {
      "text": "Which dialysis modality is most appropriate for a hemodynamically unstable patient with AKI and severe fluid overload?",
      "options": [
        {
          "label": "A",
          "text": "Intermittent hemodialysis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Continuous renal replacement therapy (CRRT)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Peritoneal dialysis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sustained low-efficiency dialysis (SLED)",
          "correct": false
        }
      ],
      "correct_answer": "B. Continuous renal replacement therapy (CRRT)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Continuous renal replacement therapy (CRRT)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Intermittent hemodialysis : Intermittent hemodialysis can cause hemodynamic instability in these patients.</li><li>\u2022 Option</li><li>\u2022 A. Intermittent hemodialysis</li><li>\u2022 Option C. Peritoneal dialysis : Peritoneal dialysis is less efficient and may not be suitable for severe fluid overload.</li><li>\u2022 Option</li><li>\u2022 C. Peritoneal dialysis</li><li>\u2022 Option D. Sustained low-efficiency dialysis (SLED) : SLED is a hybrid modality but may not be tolerated in unstable patients</li><li>\u2022 Option</li><li>\u2022 D.</li><li>\u2022 Sustained low-efficiency dialysis (SLED)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the role of continuous renal replacement therapy (CRRT) as the preferred dialysis modality for hemodynamically unstable patients with acute kidney injury (AKI) and severe fluid overload. CRRT allows for gentle and continuous removal of fluids and solutes, minimizing the risk of hypotension compared to intermittent hemodialysis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8f5bb71f",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT an absolute indication for dialysis in AKI?",
      "options": [
        {
          "label": "A",
          "text": "Severe hyperkalemia unresponsive to medical therapy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Uremic pericarditis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Severe fluid overload unresponsive to diuretics",
          "correct": false
        },
        {
          "label": "D",
          "text": "BUN level of 120 mg/dL",
          "correct": true
        }
      ],
      "correct_answer": "D. BUN level of 120 mg/dL",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) BUN level of 120 mg/Dl</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Severe hyperkalemia unresponsive to medical therapy , Option B. Uremic pericarditis and Option C. Severe fluid overload unresponsive to diuretics : These are all absolute indications for dialysis in AKI.</li><li>\u2022 Option A. Severe hyperkalemia unresponsive to medical therapy</li><li>\u2022 Option</li><li>\u2022 B. Uremic pericarditis</li><li>\u2022 Option C. Severe fluid overload unresponsive to diuretics</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The absolute indications for dialysis in AKI, which include severe hyperkalemia unresponsive to medical therapy, uremic pericarditis, and severe fluid overload unresponsive to diuretics. Elevated BUN alone is not an absolute indication, and the decision to initiate dialysis should be based on the overall clinical context and the presence of life-threatening complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d526c702",
      "audio": ""
    },
    {
      "text": "Which of the following statements about ambulatory blood pressure monitoring (ABPM) is FALSE?",
      "options": [
        {
          "label": "A",
          "text": "It measures BP every 15-30 minutes during the day and every 15-60 minutes at night.",
          "correct": false
        },
        {
          "label": "B",
          "text": "It provides a more comprehensive assessment of BP than isolated clinic readings.",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is less reliable than home BP monitoring for predicting target organ damage.",
          "correct": true
        },
        {
          "label": "D",
          "text": "An attenuated nocturnal BP dip is associated with increased cardiovascular risk.",
          "correct": false
        }
      ],
      "correct_answer": "C. It is less reliable than home BP monitoring for predicting target organ damage.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) It is less reliable than home BP monitoring for predicting target organ damage.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. It measures BP every 15-30 minutes during the day and every 15-60 minutes at night : ABPM takes frequent BP readings throughout the day and night, providing a more complete picture than clinic readings.</li><li>\u2022 Option A. It measures BP every 15-30 minutes during the day and every 15-60 minutes at night</li><li>\u2022 Option B. It provides a more comprehensive assessment of BP than isolated clinic readings : ABPM captures BP variations throughout the day, unlike isolated clinic readings.</li><li>\u2022 Option B. It provides a more comprehensive assessment of BP than isolated clinic readings</li><li>\u2022 Option D. An attenuated nocturnal BP dip is associated with increased cardiovascular risk : Less pronounced or absent nocturnal BP dips are linked to higher cardiovascular risk. ABPM helps identify these patterns.</li><li>\u2022 Option D. An attenuated nocturnal BP dip is associated with increased cardiovascular risk</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 ABPM is a valuable tool for diagnosing and managing hypertension because it provides a more complete and accurate assessment of blood pressure patterns than other methods.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ba920cad",
      "audio": ""
    },
    {
      "text": "A 48-year-old woman visits her primary care physician for an annual health examination. Her blood pressure is measured as 135/85 mmHg, with no prior history of hypertension. The physician schedules two additional blood pressure measurements over the next month. Which of the following methods is the physician using to diagnose hypertension?",
      "options": [
        {
          "label": "A",
          "text": "ABPM (Ambulatory Blood Pressure Monitoring)",
          "correct": false
        },
        {
          "label": "B",
          "text": "HBPM (Home Blood Pressure Monitoring)",
          "correct": false
        },
        {
          "label": "C",
          "text": "OBPM (Office Blood Pressure Monitoring)",
          "correct": true
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": false
        }
      ],
      "correct_answer": "C. OBPM (Office Blood Pressure Monitoring)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) OBPM (Office Blood Pressure Monitoring)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. ABPM (Ambulatory Blood Pressure Monitoring): This involves continuous blood pressure monitoring over 24 hours using a wearable device. It is more precise than OBPM but not the method described in the vignette.</li><li>\u2022 Option A. ABPM (Ambulatory Blood Pressure Monitoring):</li><li>\u2022 Option B. HBPM (Home Blood Pressure Monitoring): This involves the patient measuring their blood pressure at home using their own device. While valuable, the vignette does not mention the patient taking measurements at home.</li><li>\u2022 Option B. HBPM (Home Blood Pressure Monitoring):</li><li>\u2022 Option D. All of the above: This is incorrect as the vignette only describes the use of OBPM in a clinical setting.</li><li>\u2022 Option D. All of the above:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 The initial diagnosis of hypertension typically relies on Office Blood Pressure Monitoring (OBPM) , where multiple readings are taken in a clinical setting over a period of time to confirm the diagnosis and rule out white coat hypertension. While ABPM and HBPM are valuable tools for monitoring blood pressure and assessing its patterns, they are not typically the first step in diagnosing hypertension.</li><li>\u2022 Office Blood Pressure Monitoring (OBPM)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0e7f0426",
      "audio": ""
    },
    {
      "text": "A 54-year-old man with a family history of hypertension has normal clinic blood pressure readings (128/82 mmHg) but 24-hour ambulatory monitoring reveals consistently elevated readings (135-145/85-90 mmHg). What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "White coat hypertension",
          "correct": false
        },
        {
          "label": "B",
          "text": "Masked hypertension",
          "correct": true
        },
        {
          "label": "C",
          "text": "Primary hypertension",
          "correct": false
        },
        {
          "label": "D",
          "text": "Secondary hypertension",
          "correct": false
        }
      ],
      "correct_answer": "B. Masked hypertension",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Masked hypertension</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. White coat hypertension : This is the opposite of masked hypertension, where blood pressure is elevated in the clinic but normal outside.</li><li>\u2022 Option A. White coat hypertension</li><li>\u2022 Option C. Primary hypertension : While this patient likely has hypertension, the term \"primary\" doesn't account for the specific pattern seen here with normal clinic readings.</li><li>\u2022 Option C. Primary hypertension</li><li>\u2022 Option D. Secondary hypertension : This refers to hypertension caused by an underlying medical condition, which is not indicated in this scenario.</li><li>\u2022 Option D. Secondary hypertension</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 The diagnosis in this case is masked hypertension , characterized by normal blood pressure readings in a clinical setting but elevated readings during ambulatory monitoring. This highlights the importance of using ambulatory monitoring to accurately assess blood pressure and diagnose hypertension, especially in individuals with a family history of hypertension or other risk factors.</li><li>\u2022 masked hypertension</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fe7a4c7c",
      "audio": ""
    },
    {
      "text": "A 47-year-old woman with well-controlled type 2 diabetes presents for a routine health examination. Her in-office blood pressure is 142/88 mmHg, but her average blood pressure at home over two weeks is 122/78 mmHg. She reports feeling nervous during medical appointments. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Masked hypertension",
          "correct": false
        },
        {
          "label": "B",
          "text": "White coat hypertension",
          "correct": true
        },
        {
          "label": "C",
          "text": "Primary hypertension",
          "correct": false
        },
        {
          "label": "D",
          "text": "Secondary hypertension",
          "correct": false
        }
      ],
      "correct_answer": "B. White coat hypertension",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) White coat hypertension</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Masked hypertension: This is the opposite of white coat hypertension, with normal clinic readings but elevated blood pressure outside the clinic.</li><li>\u2022 Option A. Masked hypertension:</li><li>\u2022 Option C. Primary hypertension: While this patient may eventually develop sustained hypertension, the current findings are not consistent with this diagnosis. Primary hypertension would typically present with consistently elevated readings in both clinic and home settings.</li><li>\u2022 Option C. Primary hypertension:</li><li>\u2022 Option D. Secondary hypertension: This refers to hypertension caused by an underlying medical condition, such as renal artery stenosis or pheochromocytoma. There is no indication of secondary hypertension in this patient's history or presentation.</li><li>\u2022 Option D. Secondary hypertension:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 The diagnosis in this case is white coat hypertension , where blood pressure readings are elevated in a clinical setting but normal at home. This is often caused by anxiety or stress related to the medical environment, which the patient reports experiencing.</li><li>\u2022 white coat hypertension</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b2a620d8",
      "audio": ""
    },
    {
      "text": "A 60-year-old man with a pheochromocytoma scheduled for surgical resection presents with a blood pressure of 180/100 mmHg and episodic headaches and sweating. Which of the following medications should be initiated pre-operatively?",
      "options": [
        {
          "label": "A",
          "text": "Beta-blocker (e.g., propranolol)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alpha-blocker (e.g., phenoxybenzamine)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Calcium channel blocker (e.g., amlodipine)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Angiotensin-converting enzyme inhibitor (e.g., lisinopril)",
          "correct": false
        }
      ],
      "correct_answer": "B. Alpha-blocker (e.g., phenoxybenzamine)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Alpha-blocker (e.g., phenoxybenzamine)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Beta-blocker: Beta-blockers should be avoided initially as they can worsen hypertension by causing unopposed alpha-adrenergic stimulation. They may be added later for tachycardia control after adequate alpha-blockade is established.</li><li>\u2022 Option A. Beta-blocker:</li><li>\u2022 Option C. Calcium channel blocker: While calcium channel blockers have antihypertensive effects, they are not the first-line agents for pheochromocytoma and are less effective in controlling the episodic hypertension caused by catecholamine surges.</li><li>\u2022 Option C. Calcium channel blocker:</li><li>\u2022 Option D. Angiotensin-converting enzyme inhibitor (ACE inhibitor): ACE inhibitors are not recommended for initial blood pressure control in pheochromocytoma, as they do not directly address the underlying catecholamine excess and may not effectively control blood pressure fluctuations.</li><li>\u2022 Option D. Angiotensin-converting enzyme inhibitor (ACE inhibitor):</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Alpha-blockers are the first-line medication for pre-operative blood pressure control in patients with pheochromocytoma. They counteract the effects of catecholamines released by the tumor, preventing hypertensive crises during surgery.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "785f49ab",
      "audio": ""
    },
    {
      "text": "Which of the following congenital cardiovascular conditions is most commonly associated with hypertension in children and young adults?",
      "options": [
        {
          "label": "A",
          "text": "Patent ductus arteriosus",
          "correct": false
        },
        {
          "label": "B",
          "text": "Atrial septal defect",
          "correct": false
        },
        {
          "label": "C",
          "text": "Coarctation of the aorta",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ventricular septal defect",
          "correct": false
        }
      ],
      "correct_answer": "C. Coarctation of the aorta",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Coarctation of the aorta</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Patent ductus arteriosus (PDA): While PDA can cause heart murmurs and other symptoms, it doesn't typically cause hypertension.</li><li>\u2022 Option A. Patent ductus arteriosus (PDA):</li><li>\u2022 Option B. Atrial septal defect (ASD): ASD is a hole in the wall separating the atria, and it usually doesn't cause significant hypertension.</li><li>\u2022 Option B. Atrial septal defect (ASD):</li><li>\u2022 Option D. Ventricular septal defect (VSD): VSD is a hole in the wall separating the ventricles. It can cause heart failure if large, but doesn't typically cause isolated hypertension.</li><li>\u2022 Option D. Ventricular septal defect (VSD):</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Coarctation of the aorta is the most common congenital heart defect associated with hypertension in children and young adults. This narrowing of the aorta increases blood pressure before the constriction and can lead to various symptoms.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "24202f7a",
      "audio": ""
    },
    {
      "text": "Which of the following statements about alcohol consumption and blood pressure is TRUE?",
      "options": [
        {
          "label": "A",
          "text": "Moderate alcohol consumption has no effect on blood pressure.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Drinking three or more alcoholic drinks per day is associated with lower blood pressure.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Reducing alcohol consumption can lead to a decrease in blood pressure.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Alcohol consumption has no impact on the risk of stroke.",
          "correct": false
        }
      ],
      "correct_answer": "C. Reducing alcohol consumption can lead to a decrease in blood pressure.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Reducing alcohol consumption can lead to a decrease in blood pressure.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Moderate alcohol consumption has no effect on blood pressure : Moderate alcohol consumption may have a slight effect on blood pressure, but it is not considered neutral.</li><li>\u2022 Option A. Moderate alcohol consumption has no effect on blood pressure</li><li>\u2022 Option B. Drinking three or more alcoholic drinks per day is associated with lower blood pressure : Excessive alcohol intake is associated with higher , not lower, blood pressure.</li><li>\u2022 Option B.</li><li>\u2022 Drinking three or more alcoholic drinks per day is associated with lower blood pressure</li><li>\u2022 Option D. Alcohol consumption has no impact on the risk of stroke : Excessive alcohol intake is a risk factor for stroke.</li><li>\u2022 Option D. Alcohol consumption has no impact on the risk of stroke</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Excessive alcohol consumption is a modifiable risk factor for hypertension. Reducing alcohol intake can lead to a decrease in blood pressure, improving overall cardiovascular health and reducing the risk of stroke.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "90819dd0",
      "audio": ""
    },
    {
      "text": "A 68-year-old woman with a history of diabetes and hypertension presents for a routine check-up. Her blood pressure is 150/95 mmHg. Which of the following laboratory tests is NOT routinely recommended as part of the initial evaluation of hypertension?",
      "options": [
        {
          "label": "A",
          "text": "Serum creatinine and estimated glomerular filtration rate (eGFR)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Serum electrolytes",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fasting blood glucose",
          "correct": false
        },
        {
          "label": "D",
          "text": "Renin-aldosterone ratio",
          "correct": true
        }
      ],
      "correct_answer": "D. Renin-aldosterone ratio",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Renin-aldosterone ratio</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Serum creatinine and estimated glomerular filtration rate (eGFR), Option B. Serum electrolytes, and Option C. Fasting blood glucose : Serum creatinine, eGFR, electrolytes, and fasting blood glucose are all part of the basic laboratory tests recommended for the initial evaluation of hypertension. They help assess renal function, electrolyte balance, and underlying conditions like diabetes that can contribute to hypertension.</li><li>\u2022 Option A. Serum creatinine and estimated glomerular filtration rate (eGFR), Option B. Serum electrolytes,</li><li>\u2022 Option C. Fasting blood glucose</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 The initial evaluation of hypertension focuses on assessing end-organ damage (kidneys), identifying contributing factors (electrolytes, diabetes), and establishing a baseline for monitoring the patient's condition.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "eeeb4a91",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a typical symptom of hypertension?",
      "options": [
        {
          "label": "A",
          "text": "Headache",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fatigue",
          "correct": false
        },
        {
          "label": "C",
          "text": "Palpitations",
          "correct": true
        },
        {
          "label": "D",
          "text": "Epistaxis (nosebleed)",
          "correct": false
        }
      ],
      "correct_answer": "C. Palpitations",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Palpitations</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Headache, Option B. Fatigue and Option D. Epistaxis (nosebleed) : These symptoms can sometimes be associated with hypertension, although they are not specific</li><li>\u2022 Option A. Headache, Option B. Fatigue</li><li>\u2022 Option D. Epistaxis (nosebleed)</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Recognize that hypertension is often asymptomatic and emphasize the importance of regular blood pressure checks for early detection and management. Differentiate between potential, but not typical, symptoms of hypertension (headache, fatigue, epistaxis) and symptoms not typically associated with hypertension (palpitations). Highlight the importance of considering other potential causes for these nonspecific symptoms when evaluating a patient.</li><li>\u2022 Recognize that hypertension is often asymptomatic and emphasize the importance of regular blood pressure checks for early detection and management.</li><li>\u2022 Recognize</li><li>\u2022 Differentiate between potential, but not typical, symptoms of hypertension (headache, fatigue, epistaxis) and symptoms not typically associated with hypertension (palpitations).</li><li>\u2022 Differentiate</li><li>\u2022 Highlight the importance of considering other potential causes for these nonspecific symptoms when evaluating a patient.</li><li>\u2022 Highlight</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "52793609",
      "audio": ""
    },
    {
      "text": "Which of the following physical examination findings is most suggestive of secondary hypertension?",
      "options": [
        {
          "label": "A",
          "text": "Obesity",
          "correct": false
        },
        {
          "label": "B",
          "text": "Abdominal bruit",
          "correct": true
        },
        {
          "label": "C",
          "text": "Retinal arteriolar narrowing",
          "correct": false
        },
        {
          "label": "D",
          "text": "S4 gallop",
          "correct": false
        }
      ],
      "correct_answer": "B. Abdominal bruit",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Abdominal bruit</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Obesity : Obesity is a risk factor for primary hypertension.</li><li>\u2022 Option A.</li><li>\u2022 Obesity</li><li>\u2022 Option C. Retinal arteriolar narrowing : Retinal arteriolar narrowing is a sign of hypertensive retinopathy, a consequence of hypertension.</li><li>\u2022 Option C. Retinal arteriolar narrowing</li><li>\u2022 Option D. S4 gallop : S4 gallop can be heard in hypertensive heart disease but is not specific for secondary hypertension.</li><li>\u2022 Option D. S4 gallop</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Abdominal bruit is a significant finding on physical examination that should raise suspicion for secondary hypertension, specifically renal artery stenosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "003da87c",
      "audio": ""
    },
    {
      "text": "A 55-year-old man with hypertension presents with a blood pressure of 210/120 mmHg, headache, and mild dyspnea. He has no evidence of acute organ damage. What is the best management strategy?",
      "options": [
        {
          "label": "A",
          "text": "Immediate BP reduction to normal with IV drugs.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gradual BP reduction to 25% of initial value over 24 hours.",
          "correct": true
        },
        {
          "label": "C",
          "text": "ICU admission for aggressive BP control.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Discharge with outpatient follow-up.",
          "correct": false
        }
      ],
      "correct_answer": "B. Gradual BP reduction to 25% of initial value over 24 hours.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Gradual BP reduction to 25% of initial value over 24 hours.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Immediate BP reduction to normal with IV drugs : Immediate reduction to normal BP is too aggressive for a hypertensive urgency and could cause ischemia.</li><li>\u2022 Option A.</li><li>\u2022 Immediate BP reduction to normal with IV drugs</li><li>\u2022 Option C. ICU admission for aggressive BP control : ICU admission is unnecessary as there is no evidence of organ damage.</li><li>\u2022 Option C. ICU admission for aggressive BP control</li><li>\u2022 Option D. Discharge with outpatient follow-up : Discharge without treatment is inappropriate due to the severity of the hypertension.</li><li>\u2022 Option D. Discharge with outpatient follow-up</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 The distinction between hypertensive urgency and emergency is crucial for appropriate management. Hypertensive urgency requires gradual blood pressure reduction, while hypertensive emergency necessitates rapid intervention to prevent end-organ damage.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a35b6cba",
      "audio": ""
    },
    {
      "text": "A 72-year-old woman with a history of hypertension and chronic kidney disease presents with a blood pressure of 200/120 mmHg and acute visual disturbances. Which of the following is the most appropriate medication for initial blood pressure control in this scenario?",
      "options": [
        {
          "label": "A",
          "text": "Intravenous sodium nitroprusside",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oral clonidine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Intravenous labetalol",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sublingual nifedipine",
          "correct": false
        }
      ],
      "correct_answer": "C. Intravenous labetalol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Intravenous labetalol</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Intravenous sodium nitroprusside : Sodium nitroprusside is a potent vasodilator, but it can cause cyanide toxicity, especially in patients with renal insufficiency.</li><li>\u2022 Option A. Intravenous sodium nitroprusside</li><li>\u2022 Option B. Oral clonidine : Oral clonidine is not used in hypertensive emergencies due to its slow onset of action.</li><li>\u2022 Option B. Oral clonidine</li><li>\u2022 Option D. Sublingual nifedipine : Sublingual nifedipine is associated with unpredictable blood pressure drops and is not recommended.</li><li>\u2022 Option D. Sublingual nifedipine</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Intravenous labetalol is a preferred medication for initial blood pressure control in hypertensive emergencies, especially in patients with underlying renal disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9c968897",
      "audio": ""
    },
    {
      "text": "A 35-year-old pregnant woman in her third trimester presents with a blood pressure of 170/110 mmHg and proteinuria. Which of the following medications is most appropriate for controlling her blood pressure?",
      "options": [
        {
          "label": "A",
          "text": "Nitroprusside",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hydralazine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Enalaprilat",
          "correct": false
        },
        {
          "label": "D",
          "text": "Phentolamine",
          "correct": false
        }
      ],
      "correct_answer": "B. Hydralazine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Nitroprusside : Should be avoided in pregnancy due to the risk of cyanide toxicity to the fetus.</li><li>\u2022 Option A. Nitroprusside</li><li>\u2022 Option C. Enalaprilat (an ACE inhibitor) : Contraindicated in pregnancy due to the risk of fetal harm.</li><li>\u2022 Option C. Enalaprilat (an ACE inhibitor)</li><li>\u2022 Option D. Phentolamine : Not typically used for hypertension in pregnancy.</li><li>\u2022 Option D.</li><li>\u2022 Phentolamine</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Hydralazine is a safe and effective vasodilator for controlling blood pressure in pregnant women with preeclampsia/eclampsia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "53a570b0",
      "audio": ""
    },
    {
      "text": "A 65-year-old man with hypertension and a recent myocardial infarction (MI) is being discharged from the hospital. Which medication combination is most appropriate for his secondary prevention?",
      "options": [
        {
          "label": "A",
          "text": "ACEi + ARB + CCB",
          "correct": false
        },
        {
          "label": "B",
          "text": "BB + ACEi + Spironolactone",
          "correct": true
        },
        {
          "label": "C",
          "text": "BB + CCB + Thiazide",
          "correct": false
        },
        {
          "label": "D",
          "text": "ARB + Thiazide + Spironolactone",
          "correct": false
        }
      ],
      "correct_answer": "B. BB + ACEi + Spironolactone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) BB + ACEi + Spironolactone</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 The other options either lack evidence for post-MI benefit or include combinations that could be harmful (e.g., ACEi + ARB).</li><li>\u2022 other options</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 This combination is recommended for secondary prevention in patients with hypertension and a recent MI due to strong evidence for mortality reduction.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "58b2abb7",
      "audio": ""
    },
    {
      "text": "A 55-year-old woman with a history of hypertension and migraines presents for follow-up. Which antihypertensive medication would be most suitable given her comorbidities?",
      "options": [
        {
          "label": "A",
          "text": "Amlodipine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hydrochlorothiazide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Losartan",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metoprolol",
          "correct": true
        }
      ],
      "correct_answer": "D. Metoprolol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Metoprolol</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Other options do not have the dual indication.</li><li>\u2022 Other options</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Beta-blockers are the only class of antihypertensives indicated for both hypertension and migraine prophylaxis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7c94b242",
      "audio": ""
    },
    {
      "text": "A 35-year-old pregnant woman is diagnosed with gestational hypertension. Which of the following antihypertensive medications is considered safe for use during pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Lisinopril",
          "correct": false
        },
        {
          "label": "B",
          "text": "Losartan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Labetalol",
          "correct": true
        },
        {
          "label": "D",
          "text": "Amlodipine",
          "correct": false
        }
      ],
      "correct_answer": "C. Labetalol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Labetalol</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. ACE inhibitors (Lisinopril) and Option B. ARBs (Losartan) are contraindicated in pregnancy due to fetal risks.</li><li>\u2022 Option A. ACE inhibitors (Lisinopril)</li><li>\u2022 Option B. ARBs (Losartan)</li><li>\u2022 Option D. Amlodipine: The safety of amlodipine and hydrochlorothiazide during pregnancy is not well established.</li><li>\u2022 Option D. Amlodipine:</li><li>\u2022 amlodipine</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Labetalol is the first-line medication for gestational hypertension due to its established safety profile in pregnancy. ACE inhibitors and ARBs are contraindicated.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f82806bc",
      "audio": ""
    },
    {
      "text": "What is the first line treatment of hypertensive emergency?",
      "options": [
        {
          "label": "A",
          "text": "Oral amlodipine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oral furosemide",
          "correct": false
        },
        {
          "label": "C",
          "text": "IV labetalol",
          "correct": true
        },
        {
          "label": "D",
          "text": "IV furosemide",
          "correct": false
        }
      ],
      "correct_answer": "C. IV labetalol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) IV labetalol</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Oral amlodipine : Oral medications are not indicated in emergency situations.</li><li>\u2022 Option A. Oral amlodipine</li><li>\u2022 Option B. Oral furosemide and Option D. IV furosemide: IV furosemide is a diuretic and may be used as an adjunct, but not as the primary treatment.</li><li>\u2022 Option B. Oral furosemide</li><li>\u2022 Option D. IV furosemide:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 IV labetalol is a common first-line treatment for hypertensive emergencies due to its rapid onset and combined alpha- and beta-blocking effects.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e4a8b535",
      "audio": ""
    },
    {
      "text": "A 65-year-old man with a history of hypertension and chronic obstructive pulmonary disease (COPD) requires an additional antihypertensive medication. Which of the following would be the most appropriate choice given his comorbidities?",
      "options": [
        {
          "label": "A",
          "text": "Atenolol (beta-blocker)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lisinopril (ACE inhibitor)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Amlodipine (calcium channel blocker)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hydrochlorothiazide (thiazide diuretic) e) Losartan (ARB)",
          "correct": false
        }
      ],
      "correct_answer": "C. Amlodipine (calcium channel blocker)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Amlodipine (calcium channel blocker)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 The other options may be less suitable due to potential adverse effects on lung function or lack of evidence for specific benefits in COPD.</li><li>\u2022 other options</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Calcium channel blockers are often preferred in patients with hypertension and COPD due to their neutral effect on lung function, while beta-blockers should be used with caution.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "88b63e38",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a cause of hypovolemic hyponatremia with a urine sodium level greater than 20 mEq/L?",
      "options": [
        {
          "label": "A",
          "text": "Diuretic excess",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mineralocorticoid deficiency",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cerebral salt wasting syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Syndrome of inappropriate antidiuretic hormone secretion (SIADH)",
          "correct": true
        }
      ],
      "correct_answer": "D. Syndrome of inappropriate antidiuretic hormone secretion (SIADH)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Diuretic excess, Option B. Mineralocorticoid deficiency, and Option C. Cerebral salt wasting syndrome are all causes of hypovolemic hyponatremia with a urine sodium level greater than 20 mEq/L.</li><li>\u2022 Option A. Diuretic excess, Option B. Mineralocorticoid deficiency, and Option C. Cerebral salt wasting syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the different types of hyponatremia and their associated urine sodium levels. Hypovolemic hyponatremia with a urine sodium level greater than 20 mEq/L is caused by renal sodium loss (e.g., diuretics, mineralocorticoid deficiency) or extrarenal sodium loss (e.g., cerebral salt wasting). SIADH is euvolemic hyponatremia with high urine sodium due to excessive water retention.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1ed4536",
      "audio": ""
    },
    {
      "text": "A 68-year-old woman with a history of congestive heart failure presents with confusion, nausea, and a serum sodium level of 128 mEq/L. Her physical exam reveals jugular venous distention and bilateral crackles on lung auscultation. Which of the following is the most likely cause of her hyponatremia?",
      "options": [
        {
          "label": "A",
          "text": "Syndrome of inappropriate antidiuretic hormone secretion (SIADH)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypothyroidism",
          "correct": false
        },
        {
          "label": "C",
          "text": "Primary adrenal insufficiency",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypervolemic hyponatremia",
          "correct": true
        }
      ],
      "correct_answer": "D. Hypervolemic hyponatremia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Hypervolemic hyponatremia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Syndrome of inappropriate antidiuretic hormone secretion (SIADH): While SIADH can cause hyponatremia, it is typically euvolemic (normal fluid volume status) and does not present with signs of fluid overload like JVD and crackles.</li><li>\u2022 Option A. Syndrome of inappropriate antidiuretic hormone secretion (SIADH):</li><li>\u2022 Option B. Hypothyroidism: Hypothyroidism can cause mild hyponatremia, but it is usually not associated with the degree of hyponatremia and fluid overload seen in this patient.</li><li>\u2022 Option B. Hypothyroidism:</li><li>\u2022 Option C. Primary adrenal insufficiency: Primary adrenal insufficiency can cause hyponatremia due to aldosterone deficiency. However, it typically presents with additional symptoms such as fatigue, weight loss, and hypotension, which are not present in this patient.</li><li>\u2022 Option C. Primary adrenal insufficiency:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize the clinical presentation of hypervolemic hyponatremia, which is characterized by low serum sodium, fluid overload (JVD, edema, crackles), and often associated with underlying conditions like heart failure.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6f6bb109",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a common cause of euvolemic hyponatremia?",
      "options": [
        {
          "label": "A",
          "text": "SIADH",
          "correct": false
        },
        {
          "label": "B",
          "text": "Primary polydipsia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypothyroidism",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cirrhosis",
          "correct": true
        }
      ],
      "correct_answer": "D. Cirrhosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Cirrhosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. SIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion): In SIADH, excess antidiuretic hormone (ADH) leads to water retention, diluting sodium levels. However, the body's total sodium content remains normal, resulting in euvolemic hyponatremia.</li><li>\u2022 Option A. SIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion):</li><li>\u2022 Option B. Primary polydipsia: Excessive water intake in individuals with normal kidney function can overwhelm the kidneys' ability to excrete water, leading to dilutional hyponatremia without changes in total body sodium (euvolemic).</li><li>\u2022 Option B. Primary polydipsia:</li><li>\u2022 Option C. Hypothyroidism: In hypothyroidism, decreased thyroid hormone levels can impair water excretion by the kidneys, leading to water retention and dilutional hyponatremia without changes in total body sodium (euvolemic).</li><li>\u2022 Option C. Hypothyroidism:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand that cirrhosis is typically associated with hypervolemic hyponatremia, not euvolemic hyponatremia. Euvolemic hyponatremia is usually caused by SIADH, primary polydipsia, or hypothyroidism.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "338caddf",
      "audio": ""
    },
    {
      "text": "A patient with severe hyponatremia (serum sodium 115 mEq/L) develops seizures and altered mental status. Which of the following is the most appropriate treatment for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Fluid restriction",
          "correct": false
        },
        {
          "label": "B",
          "text": "Normal saline infusion",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypertonic saline infusion",
          "correct": true
        },
        {
          "label": "D",
          "text": "Demeclocycline",
          "correct": false
        }
      ],
      "correct_answer": "C. Hypertonic saline infusion",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Hypertonic saline infusion</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Fluid restriction : Fluid restriction is appropriate for mild hyponatremia.</li><li>\u2022 Option A. Fluid restriction</li><li>\u2022 Option B. Normal saline infusion : Normal saline is not effective in severe hyponatremia.</li><li>\u2022 Option B. Normal saline infusion</li><li>\u2022 Option D. Demeclocycline : Demeclocycline is used for chronic SIADH, not acute, severe hyponatremia.</li><li>\u2022 Option D. Demeclocycline</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize severe symptomatic hyponatremia as a medical emergency requiring prompt treatment with hypertonic saline (3%) to rapidly raise serum sodium levels and prevent neurological complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "364a59a7",
      "audio": ""
    },
    {
      "text": "Which of the following medications is NOT associated with the development of SIAD?",
      "options": [
        {
          "label": "A",
          "text": "Chlorpropamide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Carbamazepine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hydrochlorothiazide",
          "correct": true
        },
        {
          "label": "D",
          "text": "Selective serotonin reuptake inhibitors (SSRIs)",
          "correct": false
        }
      ],
      "correct_answer": "C. Hydrochlorothiazide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Hydrochlorothiazide</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Chlorpropamide , Option B. Carbamazepine , and Option D. Selective serotonin reuptake inhibitors (SSRIs ) are listed in the table as drugs that can stimulate ADH release or enhance its action, leading to SIAD.</li><li>\u2022 Option A. Chlorpropamide</li><li>\u2022 Option B. Carbamazepine</li><li>\u2022 Option D. Selective serotonin reuptake inhibitors (SSRIs</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize that hydrochlorothiazide is not associated with the development of SIADH, while other medications like chlorpropamide, carbamazepine, and SSRIs can stimulate ADH release or enhance its action, leading to SIADH. Understanding the potential side effects of medications is crucial for accurate diagnosis and management of hyponatremia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "74dfad1b",
      "audio": ""
    },
    {
      "text": "A 65-year-old patient with small cell lung cancer presents with chronic hyponatremia (125 mEq/L) due to SIADH. Which of the following is the most appropriate initial treatment?",
      "options": [
        {
          "label": "A",
          "text": "Hypertonic saline (3%) infusion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fluid restriction to 500-800 ml/day",
          "correct": true
        },
        {
          "label": "C",
          "text": "Demeclocycline",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tolvaptan",
          "correct": false
        }
      ],
      "correct_answer": "B. Fluid restriction to 500-800 ml/day",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Fluid restriction to 500-800 ml/day</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hypertonic saline (3%) infusion : Hypertonic saline is reserved for severe symptomatic hyponatremia or rapid correction in specific situations.</li><li>\u2022 Option A. Hypertonic saline (3%) infusion</li><li>\u2022 Option C. Demeclocycline : Demeclocycline is a second-line agent used if fluid restriction fails.</li><li>\u2022 Option C. Demeclocycline</li><li>\u2022 Option D. Tolvaptan : Tolvaptan is a vasopressin receptor antagonist, also considered second-line after fluid restriction.</li><li>\u2022 Option D.</li><li>\u2022 Tolvaptan</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand that fluid restriction is the most appropriate initial treatment for chronic SIADH, as it allows for gradual correction of hyponatremia without the risks associated with more aggressive therapies like hypertonic saline or medications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "85a7ae08",
      "audio": ""
    },
    {
      "text": "A 40-year-old man with a recent subarachnoid hemorrhage develops hyponatremia, hypotension, and polyuria. His urine sodium is 50 mEq/L. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Syndrome of inappropriate antidiuretic hormone secretion (SIADH)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cerebral salt wasting (CSW)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Primary polydipsia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acute tubular necrosis (ATN)",
          "correct": false
        }
      ],
      "correct_answer": "B. Cerebral salt wasting (CSW)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Cerebral salt wasting (CSW)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) : Typically euvolemic (normal fluid status) with low urine sodium (<20 mEq/L).</li><li>\u2022 Option A. Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</li><li>\u2022 Option C. Primary polydipsia : Euvolemic with low urine sodium.</li><li>\u2022 Option C. Primary polydipsia</li><li>\u2022 Option D. Acute tubular necrosis (ATN) : Would cause oliguria, not polyuria.</li><li>\u2022 Option D. Acute tubular necrosis (ATN)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize the characteristic features of cerebral salt wasting (CSW), a syndrome that can occur after brain injury and presents with hyponatremia, hypovolemia, and elevated urine sodium. Distinguishing CSW from other causes of hyponatremia, such as SIADH, is crucial for appropriate management.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "83aab534",
      "audio": ""
    },
    {
      "text": "A patient with hypovolemic hyponatremia and a urine sodium of 10 mEq/L should be treated with:",
      "options": [
        {
          "label": "A",
          "text": "Fluid restriction",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypertonic saline",
          "correct": false
        },
        {
          "label": "C",
          "text": "Normal saline",
          "correct": true
        },
        {
          "label": "D",
          "text": "Demeclocycline",
          "correct": false
        }
      ],
      "correct_answer": "C. Normal saline",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Normal saline</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Fluid restriction : Fluid restriction would worsen hypovolemia.</li><li>\u2022 Option A. Fluid restriction</li><li>\u2022 Option B. Hypertonic saline : Hypertonic saline is not the initial choice for hypovolemic hyponatremia.</li><li>\u2022 Option B. Hypertonic saline</li><li>\u2022 Option D. Demeclocycline : Demeclocycline is not indicated for hypovolemic hyponatremia.</li><li>\u2022 Option D. Demeclocycline</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand that hypovolemic hyponatremia with low urine sodium (<20 mEq/L) indicates extrarenal salt loss and should be treated with normal saline to restore both volume and sodium balance.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "885b7400",
      "audio": ""
    },
    {
      "text": "A 55-year-old man with a history of alcohol abuse presents with progressive weakness and spasticity in his legs two days after rapid correction of severe hyponatremia. Given the likely diagnosis, Which of the following neuroimaging findings would be present in the MRI?",
      "options": [
        {
          "label": "A",
          "text": "T2 hyperintensity in the basal ganglia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gadolinium enhancement in the thalamus",
          "correct": false
        },
        {
          "label": "C",
          "text": "T2 hyperintensity in the central pons with sparing of the periphery",
          "correct": true
        },
        {
          "label": "D",
          "text": "Diffusion restriction in the cerebral cortex",
          "correct": false
        }
      ],
      "correct_answer": "C. T2 hyperintensity in the central pons with sparing of the periphery",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) T2 hyperintensity in the central pons with sparing of the periphery</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. T2 hyperintensity in the basal ganglia and Option B. Gadolinium enhancement in the thalamus : These findings are not specific to CPM.</li><li>\u2022 Option A. T2 hyperintensity in the basal ganglia</li><li>\u2022 Option</li><li>\u2022 B.</li><li>\u2022 Gadolinium enhancement in</li><li>\u2022 the</li><li>\u2022 thalamus</li><li>\u2022 Option D. Diffusion restriction in the cerebral cortex : Diffusion restriction can be seen in various acute brain lesions.</li><li>\u2022 Option D. Diffusion restriction in the cerebral cortex</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the classic MRI findings of central pontine myelinolysis (CPM), which include T2 hyperintensity in the central pons with sparing of the periphery. This is a crucial diagnostic feature that can help differentiate CPM from other neurological conditions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "504b6050",
      "audio": ""
    },
    {
      "text": "Which of the following is the most effective intervention to prevent or attenuate osmotic demyelination syndrome (ODS) after overly rapid correction of hyponatremia?",
      "options": [
        {
          "label": "A",
          "text": "Intravenous mannitol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oral urea",
          "correct": false
        },
        {
          "label": "C",
          "text": "Re-lowering of plasma sodium concentration with desmopressin (DDAVP) and/or free water",
          "correct": true
        },
        {
          "label": "D",
          "text": "Corticosteroids",
          "correct": false
        }
      ],
      "correct_answer": "C. Re-lowering of plasma sodium concentration with desmopressin (DDAVP) and/or free water",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Re-lowering of plasma sodium concentration with desmopressin (DDAVP) and/or free water</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Intravenous mannitol : Mannitol may worsen osmotic stress.</li><li>\u2022 Option A. Intravenous mannitol</li><li>\u2022 Option B. Oral urea : Oral urea is not indicated in this scenario.</li><li>\u2022 Option</li><li>\u2022 B. Oral urea</li><li>\u2022 Option D. Corticosteroids : Corticosteroids have no proven benefit in preventing ODS.</li><li>\u2022 Option D. Corticosteroids</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize that re-lowering of plasma sodium concentration with desmopressin (DDAVP) and/or free water is the most effective intervention for preventing or attenuating osmotic demyelination syndrome (ODS) after overly rapid correction of hyponatremia. This is based on the principle of reversing the osmotic gradient that causes myelinolysis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ba3bee92",
      "audio": ""
    },
    {
      "text": "A 70-year-old man with dementia presents with lethargy, decreased oral intake for two days, and a serum sodium of 160 mEq/L. His weight is 70kg. Assuming total body water (TBW) is 60% of his body weight, what is his estimated free water deficit?",
      "options": [
        {
          "label": "A",
          "text": "2 liters",
          "correct": false
        },
        {
          "label": "B",
          "text": "4 liters",
          "correct": false
        },
        {
          "label": "C",
          "text": "6 liters",
          "correct": true
        },
        {
          "label": "D",
          "text": "8 liters",
          "correct": false
        }
      ],
      "correct_answer": "C. 6 liters",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) 6 liters</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. 2 liters, Option B. 4 liters and Option D. 8 liters: These options represent incorrect calculations of the free water deficit using the formula above.</li><li>\u2022 Option A. 2 liters, Option B. 4 liters</li><li>\u2022 Option D. 8 liters:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand how to calculate free water deficit in a patient with hypernatremia. This is a crucial step in determining the appropriate amount of fluid replacement needed to correct the hypernatremia safely.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5fced668",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a typical ECG finding in hyperkalemia?",
      "options": [
        {
          "label": "A",
          "text": "Peaked T waves",
          "correct": false
        },
        {
          "label": "B",
          "text": "Prolonged PR interval",
          "correct": false
        },
        {
          "label": "C",
          "text": "U waves",
          "correct": true
        },
        {
          "label": "D",
          "text": "Widened QRS complex",
          "correct": false
        }
      ],
      "correct_answer": "C. U waves",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) U waves</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Peaked T waves, Option B. Prolonged PR interval and Option D. Widened QRS complex : These are all characteristic ECG changes seen in hyperkalemia.</li><li>\u2022 Option A.</li><li>\u2022 Peaked T waves, Option B. Prolonged PR interval</li><li>\u2022 Option</li><li>\u2022 D. Widened QRS</li><li>\u2022 complex</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize the characteristic ECG findings in hyperkalemia, which include peaked T waves, prolonged PR interval, and widened QRS complex. U waves, on the other hand, are typically associated with hypokalemia. Understanding these ECG changes is crucial for the prompt diagnosis and management of hyperkalemia, a potentially life-threatening electrolyte imbalance.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9bc88da1",
      "audio": ""
    },
    {
      "text": "A 65-year-old patient with chronic kidney disease presents to the emergency department with muscle weakness, peaked T waves on ECG, and a serum potassium level of 7.0 mEq/L. Which of the following is the most appropriate immediate intervention?",
      "options": [
        {
          "label": "A",
          "text": "Administer oral sodium polystyrene sulfonate (Kayexalate)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Administer intravenous calcium gluconate",
          "correct": true
        },
        {
          "label": "C",
          "text": "Initiate hemodialysis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Administer intravenous insulin and glucose",
          "correct": false
        }
      ],
      "correct_answer": "B. Administer intravenous calcium gluconate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Administer intravenous calcium gluconate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Administer oral sodium polystyrene sulfonate ( Kayexalate) : Kayexalate is a potassium binder but works too slowly for acute hyperkalemia.</li><li>\u2022 Option A. Administer oral sodium polystyrene sulfonate (</li><li>\u2022 Kayexalate)</li><li>\u2022 Option C. Initiate hemodialysis : Hemodialysis is effective but may not be immediately available.</li><li>\u2022 Option C. Initiate hemodialysis</li><li>\u2022 Option D. Administer intravenous insulin and glucose : Insulin and glucose shift potassium intracellularly, but calcium should be given first to protect the heart.</li><li>\u2022 Option D. Administer intravenous insulin and glucose</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize the importance of administering intravenous calcium gluconate as the immediate intervention for patients presenting with hyperkalemia and ECG changes. This medication acts quickly to stabilize the cardiac membrane and protect against potentially fatal arrhythmias. While other options like Kayexalate, hemodialysis, and insulin/glucose can help lower potassium levels, they may not act rapidly enough to prevent immediate cardiac complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "28d48a96",
      "audio": ""
    },
    {
      "text": "A 55-year-old woman with a history of chronic diarrhea presents with muscle weakness, fatigue, and palpitations. Her serum potassium is 2.8 mEq/L. Which of the following ECG findings would be most consistent with her presentation?",
      "options": [
        {
          "label": "A",
          "text": "Peaked T waves",
          "correct": false
        },
        {
          "label": "B",
          "text": "Shortened QT interval",
          "correct": false
        },
        {
          "label": "C",
          "text": "Prominent U waves",
          "correct": true
        },
        {
          "label": "D",
          "text": "ST segment elevation",
          "correct": false
        }
      ],
      "correct_answer": "C. Prominent U waves",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Prominent U waves</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Peaked T waves : Peaked T waves are associated with hyperkalemia.</li><li>\u2022 Option A. Peaked T waves</li><li>\u2022 Option B. Shortened QT interval : Hypokalemia typically prolongs the QT interval, not shortens it.</li><li>\u2022 Option</li><li>\u2022 B. Shortened QT interval</li><li>\u2022 Option D. ST segment elevation : ST segment elevation is typically seen in myocardial infarction or pericarditis.</li><li>\u2022 Option D. ST segment elevation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize the characteristic ECG finding of hypokalemia, which is the presence of prominent U waves. This finding, along with the patient's symptoms (muscle weakness, fatigue, palpitations) and history of chronic diarrhea (a potential cause of potassium loss), helps confirm the diagnosis of hypokalemia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "236dfcea",
      "audio": ""
    },
    {
      "text": "A 55-year-old man with poorly controlled type 2 diabetes presents with altered mental status, Kussmaul respirations, and fruity breath. Labs show glucose of 650 mg/dL, pH of 7.20, and potassium of 2.9 mEq/L. Which mechanism best explains his hypokalemia?",
      "options": [
        {
          "label": "A",
          "text": "Increased urinary potassium excretion due to glycosuria",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vomiting-induced potassium loss",
          "correct": false
        },
        {
          "label": "C",
          "text": "Insulin deficiency-induced intracellular shift of potassium",
          "correct": false
        },
        {
          "label": "D",
          "text": "Shift of potassium into cells in exchange for hydrogen ions",
          "correct": true
        }
      ],
      "correct_answer": "D. Shift of potassium into cells in exchange for hydrogen ions",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Shift of potassium into cells in exchange for hydrogen ions.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 DKA causes urinary potassium loss and a shift of potassium into cells to buffer acidosis. This initial exchange can lead to a temporary rise in potassium, but overall potassium stores are depleted.</li><li>\u2022 Explanation :</li><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Increased urinary potassium excretion due to glycosuria: While glycosuria (glucose in the urine) can contribute to potassium loss, it is not the primary mechanism in DKA. The exchange mechanism with hydrogen ions plays a more significant role.</li><li>\u2022 Option A. Increased urinary potassium excretion due to glycosuria:</li><li>\u2022 Option B. Vomiting-induced potassium loss: Vomiting can cause hypokalemia, but it is not the dominant factor in DKA, where the underlying metabolic derangements are more critical.</li><li>\u2022 Option B. Vomiting-induced potassium loss:</li><li>\u2022 Option C. Insulin deficiency-induced intracellular shift of potassium: Insulin deficiency does initially cause potassium to shift out of cells, leading to a temporary increase in serum potassium. However, this is followed by the exchange with hydrogen ions, resulting in overall potassium depletion.</li><li>\u2022 Option C. Insulin deficiency-induced intracellular shift of potassium:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the complex mechanisms of hypokalemia in diabetic ketoacidosis (DKA). It is important to recognize that the initial hyperkalemia is transient, and the overall effect is total body potassium depletion due to the shift of potassium into cells to buffer acidosis and urinary potassium loss through glycosuria. This understanding is crucial for appropriate management of DKA, which includes potassium replacement along with insulin and fluid therapy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "12c812a9",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman presents with muscle cramps and weakness. Her serum potassium is 2.5 mEq/L. She has been taking furosemide for hypertension and reports frequent watery diarrhea. Her blood pressure is 110/70 mmHg. What is the most likely cause of her hypokalemia?",
      "options": [
        {
          "label": "A",
          "text": "Gitelman syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Primary hyperaldosteronism",
          "correct": false
        },
        {
          "label": "C",
          "text": "Renal tubular acidosis (RTA)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Diuretic use",
          "correct": true
        }
      ],
      "correct_answer": "D. Diuretic use",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Diuretic use</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Gitelman syndrome: This is a genetic disorder causing hypokalemia, but it typically presents with milder hypokalemia and often involves low urine calcium excretion, which is not mentioned in the case.</li><li>\u2022 Option A. Gitelman syndrome:</li><li>\u2022 Option B. Primary hyperaldosteronism: This condition can cause hypokalemia due to increased potassium excretion, but it usually leads to high blood pressure, which is not present in this case.</li><li>\u2022 Option B. Primary hyperaldosteronism:</li><li>\u2022 Option C. Renal tubular acidosis (RTA): RTA can also cause hypokalemia, but it often presents with metabolic acidosis, which is not mentioned in the case.</li><li>\u2022 Option C. Renal tubular acidosis (RTA):</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 To identify diuretic use as the most common cause of hypokalemia in patients presenting with muscle cramps and weakness, especially in those with a history of diuretic therapy and additional sources of potassium loss like diarrhea.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5dd1e8de",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman with a history of Crohn's disease and chronic diarrhea presents with fatigue and muscle cramps. Laboratory tests reveal a serum potassium of 3.0 mEq/L and metabolic alkalosis. Which of the following is the most likely mechanism of her hypokalemia?",
      "options": [
        {
          "label": "A",
          "text": "Renal tubular acidosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Primary hyperaldosteronism",
          "correct": false
        },
        {
          "label": "C",
          "text": "Gastrointestinal losses",
          "correct": true
        },
        {
          "label": "D",
          "text": "Diuretic use",
          "correct": false
        }
      ],
      "correct_answer": "C. Gastrointestinal losses",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Gastrointestinal losses</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Renal tubular acidosis : Renal tubular acidosis typically presents with metabolic acidosis and hyperkalemia, not alkalosis and hypokalemia.</li><li>\u2022 Option A. Renal tubular acidosis</li><li>\u2022 Option B. Primary hyperaldosteronism : Primary hyperaldosteronism causes hypokalemia but not metabolic alkalosis.</li><li>\u2022 Option</li><li>\u2022 B. Primary hyperaldosteronism</li><li>\u2022 Option D. Diuretic use : Diuretic use is not mentioned in the patient's history</li><li>\u2022 Option D. Diuretic use</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize the association between chronic diarrhea in Crohn's disease and hypokalemia with metabolic alkalosis. Gastrointestinal losses of potassium and bicarbonate can lead to this electrolyte imbalance.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "053e6691",
      "audio": ""
    },
    {
      "text": "A 28-year-old athlete presents with sudden-onset muscle paralysis after completing a marathon. He has been consuming large amounts of water during the race. His blood pressure is normal, and he is afebrile. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Hypokalemic periodic paralysis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Exertional rhabdomyolysis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Heat stroke",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hyponatremia",
          "correct": false
        }
      ],
      "correct_answer": "A. Hypokalemic periodic paralysis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Hypokalemic periodic paralysis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Exertional rhabdomyolysis: While marathon running can cause rhabdomyolysis, this would usually present with muscle pain, weakness, and dark urine, rather than sudden paralysis.</li><li>\u2022 Option B. Exertional rhabdomyolysis:</li><li>\u2022 Option C. Heat stroke: Heat stroke would likely cause hyperthermia and altered mental status, neither of which is mentioned in this scenario.</li><li>\u2022 Option C. Heat stroke:</li><li>\u2022 Option D. Hyponatremia: Excessive water intake during a marathon can cause hyponatremia, which can also lead to neurological symptoms, but sudden paralysis is more characteristic of hypokalemic periodic paralysis.</li><li>\u2022 Option D. Hyponatremia:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand that hypokalemic periodic paralysis can present with sudden-onset muscle paralysis, often triggered by strenuous exercise and excessive water intake. This condition should be considered in athletes experiencing such symptoms after intense physical activity.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1421d569",
      "audio": ""
    },
    {
      "text": "You are preparing to administer potassium chloride (KCl) to a patient with hypokalemia. The physician has ordered 40 mEq of KCl, and the available solution concentration is 2 mEq/mL. How many milliliters of KCl should you draw up in the syringe?",
      "options": [
        {
          "label": "A",
          "text": "10 mL",
          "correct": false
        },
        {
          "label": "B",
          "text": "20 mL",
          "correct": true
        },
        {
          "label": "C",
          "text": "40 mL",
          "correct": false
        },
        {
          "label": "D",
          "text": "80 mL",
          "correct": false
        }
      ],
      "correct_answer": "B. 20 mL",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) 20 mL</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the calculation of medication dosage and volume based on the desired dose and concentration of the solution. In this case, the formula Volume (mL) = Dose (mEq) / Concentration (mEq/mL) was used to determine the correct volume of potassium chloride (KCl) to administer.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0d3e3cca",
      "audio": ""
    },
    {
      "text": "A 60-year-old man with a history of chronic alcoholism and diuretic use is admitted to the hospital for community-acquired pneumonia. Laboratory results reveal a serum potassium level of 2.8 mEq/L and an ECG demonstrating flattened T waves and prominent U waves. What other electrolyte abnormality are you suspecting in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Hypernatremia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypocalcemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypermagnesemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypomagnesemia",
          "correct": true
        }
      ],
      "correct_answer": "D. Hypomagnesemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Hypomagnesemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hypernatremia: Hypernatremia (high sodium) is not typically associated with hypokalemia in this clinical scenario. Alcoholism is more often associated with hyponatremia (low sodium).</li><li>\u2022 Option A. Hypernatremia:</li><li>\u2022 Option B. Hypocalcemia: While hypocalcemia can occur in alcoholics, it is not directly related to hypokalemia and its correction is not necessary for effective potassium repletion.</li><li>\u2022 Option B. Hypocalcemia:</li><li>\u2022 Option C. Hypermagnesemia: Hypermagnesemia (high magnesium) is rare and usually occurs in the setting of renal failure or excessive magnesium intake. It is not a common finding in alcoholism.</li><li>\u2022 Option C. Hypermagnesemia:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize the association between chronic alcoholism and hypomagnesemia, which often coexists with hypokalemia. Understanding this relationship is crucial for effective treatment, as magnesium repletion is often necessary for successful potassium replacement in these patients.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "004f722c",
      "audio": ""
    },
    {
      "text": "In CKD, the remaining nephrons undergo hyperfiltration and hypertrophy to compensate for lost renal mass. Which of the following is a long-term consequence of these adaptations?",
      "options": [
        {
          "label": "A",
          "text": "Improved renal function",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glomerulosclerosis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Increased renal blood flow",
          "correct": false
        },
        {
          "label": "D",
          "text": "Decreased intrarenal pressure",
          "correct": false
        }
      ],
      "correct_answer": "B. Glomerulosclerosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Glomerulosclerosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Improved renal function: Hyperfiltration and hypertrophy only temporarily maintain GFR and eventually lead to decline.</li><li>\u2022 Option A. Improved renal function:</li><li>\u2022 Option C. Increased renal blood flow: While blood flow initially increases, it eventually decreases as nephrons are lost.</li><li>\u2022 Option C. Increased renal blood flow:</li><li>\u2022 Option D. Decreased intrarenal pressure: Intrarenal pressure actually increases due to hyperfiltration, contributing to damage</li><li>\u2022 Option D. Decreased intrarenal pressure:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand that while hyperfiltration and hypertrophy are initially compensatory mechanisms in chronic kidney disease (CKD), they ultimately lead to glomerulosclerosis and progressive decline in renal function. Recognizing this pathophysiological process highlights the importance of early intervention and management to slow down the progression of CKD.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dadc618c",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman with a 10-year history of systemic lupus erythematosus (SLE) presents with fatigue, edema, and hypertension. Laboratory tests reveal proteinuria and an estimated glomerular filtration rate (eGFR) of 40 mL/min/1.73m2. Which of the following is the most likely cause of her chronic kidney disease (CKD)?",
      "options": [
        {
          "label": "A",
          "text": "Diabetic nephropathy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypertensive nephrosclerosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lupus nephritis",
          "correct": true
        },
        {
          "label": "D",
          "text": "IgA nephropathy",
          "correct": false
        }
      ],
      "correct_answer": "C. Lupus nephritis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Lupus nephritis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Diabetic nephropathy : Diabetic nephropathy is not associated with SLE.</li><li>\u2022 Option A. Diabetic nephropathy</li><li>\u2022 Option B. Hypertensive nephrosclerosis : While hypertension can contribute to CKD, it's less likely to be the primary cause in a young patient with SLE.</li><li>\u2022 Option B. Hypertensive nephrosclerosis</li><li>\u2022 Option D. IgA nephropathy : IgA nephropathy typically presents with recurrent hematuria, not the constellation of symptoms seen here.</li><li>\u2022 Option D. IgA nephropathy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize lupus nephritis as a common and potentially serious complication of systemic lupus erythematosus (SLE). Early detection and management are crucial to preventing the progression of lupus nephritis to chronic kidney disease (CKD) and end-stage renal disease (ESRD).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "db45cb14",
      "audio": ""
    },
    {
      "text": "Which of the following statements about cardiovascular disease (CVD) in chronic kidney disease (CKD) is TRUE?",
      "options": [
        {
          "label": "A",
          "text": "CVD is the leading cause of death in patients with CKD.",
          "correct": true
        },
        {
          "label": "B",
          "text": "The risk of CVD decreases as CKD progresses.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Traditional CVD risk factors are not important in CKD patients.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Early-stage CKD patients do not require CVD screening.",
          "correct": false
        }
      ],
      "correct_answer": "A. CVD is the leading cause of death in patients with CKD.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) CVD is the leading cause of death in patients with CKD.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. The risk of CVD decreases as CKD progresses : The risk of CVD increases as CKD progresses.</li><li>\u2022 Option B. The risk of CVD decreases as CKD progresses</li><li>\u2022 Option C. Traditional CVD risk factors are not important in CKD patients : Traditional CVD risk factors are important, but CKD-specific risk factors must also be considered.</li><li>\u2022 Option C. Traditional CVD risk factors are not important in CKD patients</li><li>\u2022 Option D. Early-stage CKD patients do not require CVD screening : Early CVD screening and prevention are crucial in CKD patients.</li><li>\u2022 Option D. Early-stage CKD patients do not require CVD screening</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the significant impact of cardiovascular disease (CVD) on patients with chronic kidney disease (CKD). It is crucial to recognize that CVD is the leading cause of death in this population and that the risk increases as CKD progresses. This knowledge highlights the importance of early CVD screening and aggressive management of both traditional and CKD-specific risk factors to improve outcomes for patients with CKD.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ddc54827",
      "audio": ""
    },
    {
      "text": "A 45-year-old patient presents with a GFR of 50 mL/min/1.73m\u00b2 and an albuminuria level of 150 mg/g. According to the KDIGO 2012 classification, what is the patient's CKD stage?",
      "options": [
        {
          "label": "A",
          "text": "G2A2",
          "correct": false
        },
        {
          "label": "B",
          "text": "G3aA2",
          "correct": true
        },
        {
          "label": "C",
          "text": "G3bA2",
          "correct": false
        },
        {
          "label": "D",
          "text": "G4A2",
          "correct": false
        }
      ],
      "correct_answer": "B. G3aA2",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 According to the KDIGO 2012 classification, CKD staging is determined by both GFR levels and albuminuria categories. With a GFR of 50 mL/min/1.73m\u00b2, this patient falls into the G3a category (45-59 mL/min/1.73m\u00b2), which represents \"mildly to moderately decreased\" kidney function. The albuminuria level of 150 mg/g places the patient in the A2 category (30-300 mg/g), representing \"moderately increased\" albuminuria. Together, these values classify the patient as G3aA2.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A) G2A2 - This is incorrect because while the albuminuria category (A2) is appropriate, the GFR of 50 mL/min/1.73m\u00b2 does not fall into G2 range, which is 60-89 mL/min/1.73m\u00b2.</li><li>\u2022 Option A) G2A2</li><li>\u2022 Option C) G3bA2 - This is incorrect because G3b represents a GFR range of 30-44 mL/min/1.73m\u00b2. The patient's GFR of 50 mL/min/1.73m\u00b2 is higher than this range and falls into G3a instead.</li><li>\u2022 Option C) G3bA2</li><li>\u2022 Option D) G4A2 - This is incorrect because G4 represents a GFR range of 15-29 mL/min/1.73m\u00b2, indicating severely decreased kidney function. The patient's GFR of 50 mL/min/1.73m\u00b2 is substantially higher and does not indicate this level of severity.</li><li>\u2022 Option D) G4A2</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The KDIGO 2012 classification system evaluates CKD by incorporating both GFR and albuminuria levels, providing a more comprehensive assessment of kidney disease severity and progression risk than GFR alone.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e5575c4b",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a typical finding in uremic pericarditis?",
      "options": [
        {
          "label": "A",
          "text": "Pericardial friction rub",
          "correct": false
        },
        {
          "label": "B",
          "text": "PR depression on ECG",
          "correct": false
        },
        {
          "label": "C",
          "text": "Elevated troponin levels",
          "correct": true
        },
        {
          "label": "D",
          "text": "Diffuse ST-segment elevation on ECG",
          "correct": false
        }
      ],
      "correct_answer": "C. Elevated troponin levels",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Elevated troponin levels</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Pericardial friction rub , Option B. PR depression on ECG and Option D. Diffuse ST-segment elevation on ECG : These are classic findings in uremic pericarditis.</li><li>\u2022 Option A. Pericardial friction rub</li><li>\u2022 Option B. PR depression on ECG</li><li>\u2022 Option D.</li><li>\u2022 Diffuse ST-segment elevation on ECG</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the typical findings in uremic pericarditis, including pericardial friction rub, PR depression on ECG, and diffuse ST-segment elevation on ECG. It is important to recognize that elevated troponin levels are not a typical finding in uremic pericarditis, as it is not associated with myocardial damage.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a53ad6ea",
      "audio": ""
    },
    {
      "text": "A patient with CKD stage 5 presents with asterixis, pericarditis, and platelet dysfunction. Which of the following is the most likely explanation for these findings?",
      "options": [
        {
          "label": "A",
          "text": "Elevated BUN and creatinine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hyperphosphatemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Uremic toxin accumulation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Metabolic acidosis",
          "correct": false
        }
      ],
      "correct_answer": "C. Uremic toxin accumulation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Uremic toxin accumulation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Elevated BUN and creatinine : BUN and creatinine are markers of kidney function but don't directly cause these specific symptoms.</li><li>\u2022 Option A. Elevated BUN and creatinine</li><li>\u2022 Option B. Hyperphosphatemia : Hyperphosphatemia is a complication of CKD but is not the primary cause of these symptoms.</li><li>\u2022 Option B. Hyperphosphatemia</li><li>\u2022 Option D. Metabolic acidosis : Metabolic acidosis can contribute to uremic symptoms but is not the sole cause of these specific findings.</li><li>\u2022 Option D. Metabolic acidosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize the classic manifestations of uremia, such as asterixis, pericarditis, and platelet dysfunction. These symptoms are caused by the accumulation of uremic toxins in the body due to severely impaired kidney function. Understanding this pathophysiology is crucial for early diagnosis and management of uremia in patients with chronic kidney disease (CKD).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "44fb3839",
      "audio": ""
    },
    {
      "text": "A 58-year-old male with stage 4 CKD presents with fatigue and dyspnea on exertion. His hemoglobin level is 9.5 g/dL. Which of the following is the most likely cause of his anemia?",
      "options": [
        {
          "label": "A",
          "text": "Vitamin B12 deficiency",
          "correct": false
        },
        {
          "label": "B",
          "text": "Iron deficiency",
          "correct": false
        },
        {
          "label": "C",
          "text": "Decreased erythropoietin production",
          "correct": true
        },
        {
          "label": "D",
          "text": "Folate deficiency",
          "correct": false
        }
      ],
      "correct_answer": "C. Decreased erythropoietin production",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Decreased erythropoietin production</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Vitamin B12 deficiency and Option D. folate deficiency : Can also cause anemia, but they are less common causes of anemia in CKD. These deficiencies can be ruled out with blood tests.</li><li>\u2022 Option A. Vitamin B12 deficiency</li><li>\u2022 Option D. folate deficiency</li><li>\u2022 Option B. Iron deficiency: Iron deficiency can contribute to anemia in some patients with CKD, but it is not the primary cause. Iron stores are usually assessed before starting treatment for anemia in CKD.</li><li>\u2022 Option B. Iron deficiency:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand that the primary cause of anemia in chronic kidney disease (CKD) is decreased erythropoietin (EPO) production due to kidney damage. This knowledge is essential for the accurate diagnosis and management of anemia in CKD patients, as it guides the choice of treatment, which often involves administering erythropoiesis-stimulating agents (ESAs) to compensate for the lack of endogenous EPO.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2345c431",
      "audio": ""
    },
    {
      "text": "Which of the following medications directly suppresses PTH secretion in CKD patients with secondary hyperparathyroidism?",
      "options": [
        {
          "label": "A",
          "text": "Calcium carbonate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sevelamer",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cinacalcet",
          "correct": false
        },
        {
          "label": "D",
          "text": "Calcitriol",
          "correct": true
        }
      ],
      "correct_answer": "D. Calcitriol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Calcitriol</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Calcium carbonate : Calcium carbonate is a phosphate binder, not a PTH suppressant.</li><li>\u2022 Option A. Calcium carbonate</li><li>\u2022 Option B. Sevelamer : Sevelamer is a phosphate binder, not a PTH suppressant.</li><li>\u2022 Option B. Sevelamer</li><li>\u2022 Option C. Cinacalcet : Cinacalcet is a calcimimetic that increases the sensitivity of the parathyroid gland to calcium, indirectly lowering PTH</li><li>\u2022 Option C. Cinacalcet</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the different classes of medications used to manage secondary hyperparathyroidism in chronic kidney disease (CKD), and to recognize that calcitriol is the only medication listed that directly suppresses parathyroid hormone (PTH) secretion.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4bf27958",
      "audio": ""
    },
    {
      "text": "A patient with CKD stage 3 has a PTH level of 150 pg/mL and a normal serum calcium level. Which of the following is the most appropriate management strategy?",
      "options": [
        {
          "label": "A",
          "text": "No treatment is necessary at this time",
          "correct": true
        },
        {
          "label": "B",
          "text": "Initiate calcium carbonate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Initiate calcitriol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Initiate cinacalcet",
          "correct": false
        }
      ],
      "correct_answer": "A. No treatment is necessary at this time",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) No treatment is necessary at this time</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Initiate calcium carbonate , Option C. Initiate calcitriol and Option D. Initiate cinacalcet : These medications are not indicated unless PTH levels exceed the target range or there are other complications of CKD-MBD.</li><li>\u2022 Option B. Initiate calcium carbonate</li><li>\u2022 Option C. Initiate calcitriol</li><li>\u2022 Option D.</li><li>\u2022 Initiate</li><li>\u2022 cinacalcet</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand that not all elevated PTH levels in CKD require immediate intervention. Treatment decisions should be based on the severity of PTH elevation, calcium levels, and the presence of other complications of CKD-mineral bone disease (CKD-MBD).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6d15f843",
      "audio": ""
    },
    {
      "text": "A 63-year-old woman with kidney failure on dialysis develops a rapidly progressing, painful nodule on her abdomen that breaks down and forms an open sore (see image). She takes medications for high blood pressure (losartan) and blood clots (warfarin). Which of the following is LEAST likely about her condition?",
      "options": [
        {
          "label": "A",
          "text": "Calcium supplements may worsen it.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Blood vessel blockage is involved.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pseudomonas infection is common.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Warfarin use is a risk factor.",
          "correct": false
        }
      ],
      "correct_answer": "C. Pseudomonas infection is common.",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-174056.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Pseudomonas infection is common.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Calcium supplements may worsen it: True. Calcium-based phosphate binders and vitamin D analogs can contribute to the development of calciphylaxis.</li><li>\u2022 Option A. Calcium supplements may worsen it:</li><li>\u2022 Option B. Calcium supplements may worsen it: True. Calciphylaxis is characterized by calcification of small blood vessels leading to ischemia and necrosis.</li><li>\u2022 Option B. Calcium supplements may worsen it:</li><li>\u2022 Option D. Warfarin use is a risk factor: True. Warfarin is associated with an increased risk of calciphylaxis.</li><li>\u2022 Option D. Warfarin use is a risk factor:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the key features and risk factors associated with calciphylaxis, a rare but severe complication of chronic kidney disease (CKD). It is important to recognize that while Pseudomonas infection can occur in any open wound, it is not the most common pathogen associated with calciphylaxis. Staphylococcus aureus is more frequently implicated in these infections.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "42a04ee2",
      "audio": ""
    },
    {
      "text": "Which of the following is the most common presenting symptom in patients with ADPKD?",
      "options": [
        {
          "label": "A",
          "text": "Hypertension",
          "correct": false
        },
        {
          "label": "B",
          "text": "Flank or back pain",
          "correct": true
        },
        {
          "label": "C",
          "text": "Gross hematuria",
          "correct": false
        },
        {
          "label": "D",
          "text": "Urinary tract infection",
          "correct": false
        }
      ],
      "correct_answer": "B. Flank or back pain",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Flank or back pain</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hypertension : Hypertension is common but may not be the initial presenting symptom.</li><li>\u2022 Option A. Hypertension</li><li>\u2022 Option C. Gross hematuria : Gross hematuria occurs in a significant proportion of patients but is less common than pain.</li><li>\u2022 Option C. Gross hematuria</li><li>\u2022 Option D. Urinary tract infection : Urinary tract infections are a complication but not the most common initial presentation.</li><li>\u2022 Option D. Urinary tract infection</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize that flank or back pain is the most common presenting symptom in autosomal dominant polycystic kidney disease (ADPKD). This pain is often due to cyst enlargement, hemorrhage, or infection and may be the first sign of the disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "127af10f",
      "audio": ""
    },
    {
      "text": "Which of the following medications is FDA-approved for slowing kidney disease progression in ADPKD?",
      "options": [
        {
          "label": "A",
          "text": "Tolvaptan",
          "correct": true
        },
        {
          "label": "B",
          "text": "Everolimus",
          "correct": false
        },
        {
          "label": "C",
          "text": "Octreotide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cinacalcet",
          "correct": false
        }
      ],
      "correct_answer": "A. Tolvaptan",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Tolvaptan</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Everolimus : Everolimus is an mTOR inhibitor under investigation but not FDA-approved for ADPKD.</li><li>\u2022 Option B. Everolimus</li><li>\u2022 Option C. Octreotide : Octreotide is a somatostatin analogue with potential benefits but not FDA-approved.</li><li>\u2022 Option C. Octreotide</li><li>\u2022 Option D. Cinacalcet : Cinacalcet is used to treat secondary hyperparathyroidism in CKD</li><li>\u2022 Option D.</li><li>\u2022 Cinacalcet</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand that tolvaptan is the only FDA-approved medication for slowing the progression of kidney disease in ADPKD. It works by inhibiting vasopressin, which plays a role in cyst growth.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "85b0232e",
      "audio": ""
    },
    {
      "text": "A 62-year-old end-stage renal disease (ESRD) patient requires hemodialysis access. Given the need for long-term vascular access, which arteriovenous fistula (AVF) would be the most suitable choice for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Brachiocephalic AVF",
          "correct": false
        },
        {
          "label": "B",
          "text": "Radiocephalic AVF",
          "correct": true
        },
        {
          "label": "C",
          "text": "Brachiobasilic AVF",
          "correct": false
        },
        {
          "label": "D",
          "text": "Femoral AVF",
          "correct": false
        }
      ],
      "correct_answer": "B. Radiocephalic AVF",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Radiocephalic AVF</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Brachiocephalic AVF and Option C. Brachiobasilic AVF : Larger vessels, higher flow, risk of steal syndrome/heart failure.</li><li>\u2022 Option A. Brachiocephalic AVF</li><li>\u2022 Option C. Brachiobasilic AVF</li><li>\u2022 Option D. Femoral AVF : Higher infection risk, deeper cannulation</li><li>\u2022 Option D. Femoral AVF</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the importance of choosing the most suitable arteriovenous fistula (AVF) for long-term hemodialysis access. The radiocephalic AVF at the wrist is generally preferred due to its lower complication rates, easier cannulation, and preservation of future access sites.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f6adc3e6",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a determinant of hemodialysis efficiency?",
      "options": [
        {
          "label": "A",
          "text": "Blood flow rate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dialysate flow rate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dialyzer characteristics",
          "correct": false
        },
        {
          "label": "D",
          "text": "Patient's age",
          "correct": true
        }
      ],
      "correct_answer": "D. Patient's age",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Patient's age</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Blood flow rate: Higher blood flow rates allow for greater clearance of solutes from the bloodstream across the dialyzer membrane.</li><li>\u2022 Option A. Blood flow rate:</li><li>\u2022 Option B. Dialysate flow rate: Faster dialysate flow rates create a steeper concentration gradient between the blood and dialysate, enhancing the diffusion of solutes from the blood into the dialysate.</li><li>\u2022 Option B. Dialysate flow rate:</li><li>\u2022 Option C. Dialyzer characteristics: The dialyzer membrane's surface area, porosity, and permeability all influence how effectively solutes are removed from the blood. For instance, a larger surface area allows for more clearance of solutes.</li><li>\u2022 Option C. Dialyzer characteristics:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize the key factors that determine hemodialysis efficiency, including blood flow rate, dialysate flow rate, and dialyzer characteristics. While a patient's age can influence their overall dialysis needs, it doesn't directly affect the efficiency of the hemodialysis process itself.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f18b4ef2",
      "audio": ""
    },
    {
      "text": "Which of the following findings is NOT typically associated with peritonitis in peritoneal dialysis?",
      "options": [
        {
          "label": "A",
          "text": "Cloudy dialysate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Abdominal pain",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fever",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypotension",
          "correct": true
        }
      ],
      "correct_answer": "D. Hypotension",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Hypotension</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Cloudy dialysate, Option B. Abdominal pain and Option C. Fever : Cloudy dialysate, abdominal pain, and fever are classic signs of peritonitis.</li><li>\u2022 Option A.</li><li>\u2022 Cloudy dialysate, Option B. Abdominal pain</li><li>\u2022 Option C. Fever</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the typical clinical presentation of peritonitis in peritoneal dialysis, including cloudy dialysate, abdominal pain, and fever. Recognizing these signs and symptoms is crucial for early diagnosis and treatment to prevent complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "20f13784",
      "audio": ""
    },
    {
      "text": "A 72-year-old man with end-stage renal disease and uremia starts hemodialysis. During the session, he becomes restless, confused, and develops a headache. Which of the following is the most likely cause of his symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Acute intradialytic hypotension",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hemodialysis-associated thrombosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dialysis disequilibrium syndrome",
          "correct": true
        },
        {
          "label": "D",
          "text": "Air embolism during hemodialysis",
          "correct": false
        }
      ],
      "correct_answer": "C. Dialysis disequilibrium syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Dialysis disequilibrium syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Acute intradialytic hypotension: This would typically cause dizziness, lightheadedness, or fainting, but not the neurologic symptoms described.</li><li>\u2022 Option A. Acute intradialytic hypotension:</li><li>\u2022 Option B. Hemodialysis-associated thrombosis: This would cause issues with the dialysis access site (e.g., pain, swelling, decreased blood flow) rather than neurologic symptoms.</li><li>\u2022 Option B. Hemodialysis-associated thrombosis:</li><li>\u2022 Option D. Air embolism during hemodialysis: This is a rare but serious complication that would present with sudden respiratory distress, chest pain, and potentially cardiac arrest.</li><li>\u2022 Option D. Air embolism during hemodialysis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize the signs and symptoms of dialysis disequilibrium syndrome (DDS), a complication that can occur during the initial stages of hemodialysis in patients with uremia. DDS is caused by the rapid removal of urea, creating an osmotic gradient that leads to cerebral edema and neurological symptoms.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "468ea273",
      "audio": ""
    },
    {
      "text": "A patient with secondary hyperparathyroidism due to end-stage renal disease undergoes a successful parathyroidectomy. During their first hemodialysis session post-surgery, which of the following dialysate modifications would be most appropriate?",
      "options": [
        {
          "label": "A",
          "text": "Increased potassium concentration",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decreased potassium concentration",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased calcium concentration",
          "correct": true
        },
        {
          "label": "D",
          "text": "Decreased calcium concentration",
          "correct": false
        }
      ],
      "correct_answer": "C. Increased calcium concentration",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Increased calcium concentration</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Increased potassium concentration : Not relevant to HBS management. Potassium levels may need to be adjusted based on the patient's serum potassium.</li><li>\u2022 Option A. Increased potassium</li><li>\u2022 concentration</li><li>\u2022 Option B. Decreased potassium concentration : This could worsen hypokalemia, which is not a primary concern in HBS.</li><li>\u2022 Option B. Decreased potassium</li><li>\u2022 concentration</li><li>\u2022 Option D. Decreased calcium concentration : This would exacerbate the existing hypocalcemia in HBS and should be avoided</li><li>\u2022 Option D. Decreased calcium concentration</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the importance of modifying dialysate calcium concentration after parathyroidectomy in patients with secondary hyperparathyroidism due to end-stage renal disease. Increasing the calcium concentration helps prevent severe hypocalcemia and its associated complications, known as \"hungry bone syndrome\" (HBS).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b2d2b9cf",
      "audio": ""
    },
    {
      "text": "Which of the following immunosuppressive medications binds to CD80 and CD86 on antigen-presenting cells, inhibiting T-cell activation?",
      "options": [
        {
          "label": "A",
          "text": "Sirolimus",
          "correct": false
        },
        {
          "label": "B",
          "text": "Everolimus",
          "correct": false
        },
        {
          "label": "C",
          "text": "Belatacept",
          "correct": true
        },
        {
          "label": "D",
          "text": "Basiliximab",
          "correct": false
        }
      ],
      "correct_answer": "C. Belatacept",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Belatacept</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Sirolimus: Sirolimus (rapamycin) is an mTOR inhibitor. It works by forming a complex with FKBP-12, which then binds to and inhibits the mTOR protein, thus blocking T-cell proliferation.</li><li>\u2022 Option A. Sirolimus:</li><li>\u2022 Option B. Everolimus: Everolimus is also an mTOR inhibitor and has a similar mechanism of action to sirolimus.</li><li>\u2022 Option B. Everolimus:</li><li>\u2022 Option D. Basiliximab: Basiliximab is a monoclonal antibody that binds to the IL-2 receptor on activated T cells, preventing their proliferation.</li><li>\u2022 Option D. Basiliximab:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand the different mechanisms of action of immunosuppressive medications used in transplantation. Belatacept is unique in its ability to specifically inhibit T-cell activation by blocking the interaction between CD80/CD86 on antigen-presenting cells and CD28 on T cells.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6ee95a72",
      "audio": ""
    },
    {
      "text": "A 48-year-old kidney transplant recipient, 3 weeks post-transplant, presents with a sudden rise in serum creatinine, decreased urine output, and tenderness over the allograft. Doppler ultrasound shows increased renal artery resistance. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute tubular necrosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Calcineurin inhibitor toxicity",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acute T-cell mediated rejection",
          "correct": true
        },
        {
          "label": "D",
          "text": "Antibody-mediated rejection",
          "correct": false
        }
      ],
      "correct_answer": "C. Acute T-cell mediated rejection",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Acute T-cell mediated rejection</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Acute tubular necrosis (ATN): ATN usually occurs immediately post-transplant and is less likely weeks later. It would not typically cause allograft tenderness or increased arterial resistance on Doppler.</li><li>\u2022 Option A. Acute tubular necrosis (ATN):</li><li>\u2022 Option B. Calcineurin inhibitor toxicity: While this can cause elevated creatinine, it usually presents with more gradual onset and less specific symptoms.</li><li>\u2022 Option B. Calcineurin inhibitor toxicity:</li><li>\u2022 Option D. Antibody-mediated rejection: This is less likely to occur early post-transplant and typically presents with more severe features like glomerulitis and vascular injury on biopsy.</li><li>\u2022 Option D. Antibody-mediated rejection:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize the clinical presentation and diagnostic findings of acute T-cell mediated rejection in kidney transplant recipients. This type of rejection typically occurs early post-transplant and presents with a sudden rise in creatinine, decreased urine output, allograft tenderness, and increased renal artery resistance on Doppler ultrasound. Differentiating this from other causes of graft dysfunction is crucial for prompt and appropriate intervention.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a84bec5f",
      "audio": ""
    },
    {
      "text": "A kidney transplant recipient with a positive CMV IgG serostatus develops fever, leukopenia, and elevated liver enzymes 4 months post-transplant. Which of the following is the most appropriate diagnostic test to confirm CMV infection?",
      "options": [
        {
          "label": "A",
          "text": "Blood culture",
          "correct": false
        },
        {
          "label": "B",
          "text": "CMV PCR",
          "correct": true
        },
        {
          "label": "C",
          "text": "Liver biopsy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lung biopsy",
          "correct": false
        }
      ],
      "correct_answer": "B. CMV PCR",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) CMV PCR</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Blood culture : Blood culture is not useful for diagnosing viral infections like CMV.</li><li>\u2022 Option A. Blood culture</li><li>\u2022 Option C. Liver biopsy : Liver biopsy is invasive and not typically needed for diagnosing CMV infection.</li><li>\u2022 Option C. Liver biopsy</li><li>\u2022 Option D. Lung biopsy : Lung biopsy is not indicated in this scenario as the primary organ involvement is not the lungs.</li><li>\u2022 Option D. Lung biopsy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand that CMV PCR is the most sensitive and specific test for diagnosing CMV infection in transplant recipients, allowing for early detection and treatment to prevent complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e3efdd2c",
      "audio": ""
    },
    {
      "text": "A kidney transplant recipient presents 3 months post-transplant with fever, dry cough, and shortness of breath. Chest X-ray reveals bilateral interstitial infiltrates. Which of the following is the most likely diagnosis and the drug of choice for its prophylaxis?",
      "options": [
        {
          "label": "A",
          "text": "Cytomegalovirus (CMV) \u2013 Valganciclovir",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pneumocystis jirovecii pneumonia (PJP) \u2013 Trimethoprim-sulfamethoxazole (TMP-SMX)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Aspergillus fumigatus \u2013 Fluconazole",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nocardia asteroides \u2013 Ganciclovir",
          "correct": false
        }
      ],
      "correct_answer": "B. Pneumocystis jirovecii pneumonia (PJP) \u2013 Trimethoprim-sulfamethoxazole (TMP-SMX)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Pneumocystis jirovecii pneumonia (PJP) \u2013 Trimethoprim-sulfamethoxazole (TMP-SMX)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Cytomegalovirus (CMV) \u2013 Valganciclovir : Cytomegalovirus (CMV) is a common infection after transplantation, but it usually presents with nonspecific symptoms like fever and fatigue, and it does not typically cause the classic chest X-ray findings of PJP. Valganciclovir is used for CMV prophylaxis and treatment.</li><li>\u2022 Option A. Cytomegalovirus (CMV) \u2013 Valganciclovir</li><li>\u2022 Option C. Aspergillus fumigatus \u2013 Fluconazole : Aspergillus fumigatus is a mold infection that can cause pulmonary symptoms, but it is less common in the early post-transplant period. Fluconazole is an antifungal medication, not used for PJP prophylaxis.</li><li>\u2022 Option C. Aspergillus fumigatus \u2013 Fluconazole</li><li>\u2022 Option D. Nocardia asteroides \u2013 Ganciclovir : Nocardia asteroides is a bacterial infection that can cause pulmonary or disseminated disease, but it is less common than PJP in this setting. Ganciclovir is used for CMV prophylaxis and treatment</li><li>\u2022 Option D. Nocardia asteroides \u2013 Ganciclovir</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To recognize the clinical presentation and chest X-ray findings of Pneumocystis jirovecii pneumonia (PJP) in kidney transplant recipients and to understand that trimethoprim-sulfamethoxazole (TMP-SMX) is the preferred prophylactic agent for PJP.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fb3c4519",
      "audio": ""
    },
    {
      "text": "Which of the following is the leading cause of death in kidney transplant recipients?",
      "options": [
        {
          "label": "A",
          "text": "Infection",
          "correct": false
        },
        {
          "label": "B",
          "text": "Malignancy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cardiovascular events",
          "correct": true
        },
        {
          "label": "D",
          "text": "Graft failure",
          "correct": false
        }
      ],
      "correct_answer": "C. Cardiovascular events",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Cardiovascular events</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Infection: While infection is a significant cause of mortality in transplant recipients (18%), it is not as common as cardiovascular events.</li><li>\u2022 Option A. Infection:</li><li>\u2022 Option B. Malignancy : Malignancy, including PTLD, is also a concern for transplant recipients (17%), but it is still less common than cardiovascular events.</li><li>\u2022 Option B.</li><li>\u2022 Malignancy</li><li>\u2022 Option D. Graft failure: While graft failure can lead to death, it is not as frequent a cause as cardiovascular events.</li><li>\u2022 Option D. Graft failure:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 To understand that cardiovascular events are the leading cause of death in kidney transplant recipients, highlighting the importance of cardiovascular risk assessment and management in this population.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a4e90483",
      "audio": ""
    }
  ]
}